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As femoral access percutaneous cardiac interventions (PCIs) increase in the United States, so 
will vascular complications. Nurses play a vital role in increasing comfort and decreasing 
vascular complications in patients who have undergone a femoral access PCI, through 
monitoring and early ambulation. Early ambulation is supported by the literature, yet a sacred 
cow of nursing, prolonged bed rest, continues in clinical practice with varied nursing perception 
of optimal early ambulation time. The purpose of this integrative review was to assess if nursing 
perception of optimal ambulation time after a femoral access PCI, four hours, has any impact on 
vascular complications in adult patients. The 15 articles reviewed showed that low-risk patients 
are eligible for early ambulation at four hours or less post-femoral access PCI and nurses should 
consider a patient’s history and risk factors prior to ambulating the patient. Other themes include 
lack of evidence from clinical practice guidelines (CPGs), varying definitions of low-risk 
patients and variables, methodological study flaws, lack of evidence linking risk factors and 
early ambulation, and nursing need for early ambulation education. Wagner’s Chronic Care 
Model’s elements of decision support and clinical information systems were used to guide the 
nursing implications and recommendations. Decision support systems such as evidence-based 
CPGs, are needed for post-PCI nursing care in the United States. Clinical information systems 
such as the electronic health record, can help guide and support post-PCI nursing care in the 
form of flow sheets, clinical decision tools, and clinical pathways. Additional nursing 
implications and recommendations include nursing education based on the latest evidence-based 
literature, standardizing variable definitions, and a call for an additional randomized control trial 
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Introduction to Inquiry  
 The primary purpose of this integrative review is to assess if early ambulation at four 
hours or less has an effect on vascular complications after a femoral access percutaneous cardiac 
intervention (PCI). This section will cover the background of the problem, a global 
understanding of the PCI process, rationale of inquiry, the clinical question posed in PICO 
format (Gray, Grove, & Sutherland, 2017), and the method of inquiry. A global understanding of 
the PCI includes understanding what a PCI is, indications for the procedure, adjunctive therapies, 
the PCI process, and vascular risk factors and complications (Abdollahi, Mehranfard, 
Behnampour, & Kordnejad, 2015; Benjamin et al., 2019; Davis & Shiel, 2019; Kern, Sorajja, & 
Lim, 2016; Levine et al., 2011; Mann, Zipes, Libby, Bonow, & Braunwald, 2019; Sajnani & 
Bogart, 2013; Sandoval et al., 2017; Schiks et al., 2008; Stouffer & Peter, 2016; Upvall, 
Vougault, Pigon, & Swartzman, 2019; Wentworth et al., 2018; Woods, Froelicher, Motzer, & 
Bridges, 2010). 
Background  
Every forty seconds, an American will suffer from a myocardial infarction (MI; 
Benjamin et al., 2019), which is an indication for a PCI, or a non-surgical cardiac procedure 
(Stouffer & Peter, 2016). In 2018, the number of PCIs performed was “more than 950,000 per 
year and rising” (Kim & Zamanian, 2018, para. 4) within the United States (U.S.). The 
hospitalization cost for a MI often includes a PCI, which is usually the most expensive part of the 
hospital experience for a patient with a MI. The cost of a PCI without complications in the U.S. 
averages around $18,931. Vascular complications, which are reported in 1.4% of patients 







bill (Cowper et al., 2019). Nurses play an important role in the recovery and outcomes of the 
patients, especially during the post-procedural period when many vascular complications can 
arise (Rolley, Davidson, Salamonson, Fernandez, & Dennison, 2009; Rolley, Salamonson, 
Wensley, Dennison, & Davidson, 2011). Cowper et al. (2019), estimate that 20% of the cost of a 
PCI is allocated for post-procedure care, making the role of the nurse essential in ensuring 
optimal outcomes for patients undergoing a PCI (Rolley et al., 2009; Rolley et al., 2011).  
Clinical nurses are responsible for pulling the introducer sheath, assessing for vascular 
complications while a patient is on bed rest, and safely ambulating the patient (Rolley et al., 
2009; Rolley et al., 2011). A patient who has had a femoral access PCI must be maintained on 
bed rest for several hours to maintain hemostatis and prevent vascular complications (Abdollahi 
et al., 2015). This prolonged bed rest can cause back pain, urinary retention, and patient 
dissatisfaction (Augustin, Quadros, & Samento-Leite, 2010; Mohammady et al., 2013; Schiks et 
al., 2008). Despite an uptick in literature addressing and advocating for early ambulation post-
femoral PCI to decrease these side effects and promote same day discharge, nurses continue to 
practice prolonged bed rest in order to prevent vascular complications (Augustin et al., 2010; 
Kim et al., 2013; Rolley, Davidson, Salamonson, Dennison, & Davidson, 2010; Schiks et al.,  
2008). Prolonged bed rest after a PCI, like many nursing actions, are not based in evidence, but 
on experimental care (Abdollahi et al., 2015). This type of practice can be viewed as a sacred 
cow of the nursing practice (Upvall et al., 2019). Sacred cows are “old habits in practice, 
considered routine and above dispute regardless of evidence to the contrary” (Hanrahan et al., 
2015, p. 3). These sacred cows are tightly woven into clinical practice and often not based in 







 The research and implementation of evidence-based nursing cares has not evolved as 
quickly as medical aspects of the PCIs. Medical aspects of the PCI procedure have evolved 
rapidly and include advances in adjunctive therapies, technologies, and procedural techniques 
(Matte, de Souza Hilário, Reich, Aliti, & Rabelo-Silva, 2016; Schiks et al., 2008). One possible 
explanation may be that “vascular sheath removal, mobilization, and ambulation protocols vary 
according to the device protocol and hospital policy” (Moser & Riegel, 2008, p. 543).  There is 
also little evidence to support early ambulation post-femoral PCI in the U.S. from clinical 
practice guidelines (CPGs) that minimize vascular complications (Levine et al., 2011; Rolley et 
al., 2010; Rolley et al., 2011).  
Nurses not only play a vital role in ensuring comfort after a PCI, their ability to assess for 
vascular complications and ambulate patients safely could have financial implications for the 
hospital system (Augustin et al., 2010; Cowper et al., 2019). To debunk this sacred cow of 
nursing practice, a global understanding of the femoral PCI procedure, indications for a PCI, 
adjunctive therapies, vascular risk factors and complications must be addressed—and it must be 
done prior to promoting the evolution of evidence-based nursing interventions such as early 
ambulation post-femoral PCI (Abdollahi et al., 2015; Benjamin et al., 2019; Davis & Shiel, 
2019; Kern et al., 2016; Levine et al., 2011; Mann et al., 2019; Sajnani & Bogart, 2013; 
Sandoval et al., 2017; Schiks et al., 2008; Stouffer & Peter, 2016; Upvall et al., 2019; Wentworth 
et al., 2018; Woods, Froelicher, Motzer, & Bridges, 2010). 
PCI Definition and Indications. PCI is a term that encompasses several interventional 
procedures in the coronary arteries with a percutaneous approach (Woods et al., 2010). It 
includes procedures undertaken after the diagnostic coronary angiogram (Kern et al., 2016), and 







et al., 2018; Woods et al., 2010). Clinical indications for PCIs include acute ST-elevation MI, 
non-ST-elevation MI, high-risk stress test results, unstable angina, and anginal symptoms 
equivalents (Stouffer & Peter, 2016).  
Femoral access in PCIs is the most popular access point for PCIs—accounting for 74.5% 
of all PCIs—in the U.S. catherization labs, despite an increase in radial access within the last 
several years (Benjamin et al., 2019; Mann et al., 2019; Stouffer & Peter, 2016). Implications for 
a femoral access PCI over a radial access PCI include coronary chronic total occlusion PCIs, 
cases needing mechanical circulatory support devices for cardiogenic shock, cardiac arrest 
(Sandoval et al., 2017), and in contraindications to radial access such as subclavian abnormalities 
(Kern et al., 2016). Benjamin et al. (2019) reports that the risk of vascular injury post-procedure 
is approximately 1.4%. This complication rate may have declined from earlier PCI approaches 
due to advances in drug regimes, decreased sheath size, procedural enhancements, increased 
interventionists knowledge, and advancement in procedural equipment such as the vascular 
closure device (Moser & Riegel, 2008; Woods et al., 2010). This number may seem small, 
however if 950,000 PCIs were completed in 2018, this would mean there was around 13,300 
related vascular events that year and potentially an increased cost of around $27 million dollars 
(Kim & Zamanian, 2018).  
PCI Adjunctive Therapies and Process. Prior to any type of PCI, dual oral antiplatelet 
therapy should be given. This includes an aspirin (81-325 milligrams) and a P2Y12 platelet 
inhibitor (Levine et al., 201l; Stouffer & Peter, 2016), and should be continued after the 
procedure based on guideline-based timeframes (Levine et al., 2011). These drugs work to lower 
factors that increase platelet aggregation, stent thrombosis, and are recommended for all patients 







catheter-based coronary angiography begins, or obtaining coronary, ventricular, and peripheral 
vascular images. Coronary angiography is the gold standard for diagnosing coronary artery 
disease and visualizing lesions for intervention (Kern et al., 2016).  
Once appropriate imaging and data gathering is complete within a coronary angiogram, 
intravenous (IV) anticoagulants, antiplatelets, or direct thrombin inhibitor agents are usually 
given (usually if dual antiplatelet therapy was not given during the pre-procedure time period) 
prior to guidewire insertion (Stouffer & Peter, 2016). These IV agents work to decrease adverse 
events of the invasive procedure such as ischemia and thrombus formation at the arterial site of 
injury, on the catheters, and on the guidewires (Levine et al., 2011). A guidewire is then 
introduced over the stenotic coronary artery lesion, with possible vessel preparation with a semi-
compliant balloon or an atherectomy device. Finally, the stent of choice is passed over the 
guidewire and deployed (Stouffer & Peter, 2016). Whether a vascular compression device, 
manual compression, or another compression device such as the FemoStop™, has been used to 
maintain hemostatis the femoral access site, careful monitoring for vascular complications 
should occur to assess for potential vascular complications from the puncture site and 
surrounding area (Kern et al., 2016). Bed rest is then started to maintain hemostasis with duration 
dependent on hospital policy and device protocol (Moser & Riegel, 2008).  
Vascular Risk Factors. The at-risk groups for vascular complications include female 
gender, low body weight, advanced age, use of anticoagulants medications, use of antiplatelet 
medications such as glycoprotein (GP) IIb/IIIa inhibitors, large catheter size as defined by 
provider, length of time catheter is in place, peripheral vascular disease, diabetes mellitus, 
hypertension, renal dysfunction, and urgent invention (Merriweather & Sulzbach-Hoke, 2012; 







females tend to have common femoral arteries that are shorter in length and smaller in diameter 
than their male counterparts. Second, post-menopausal women are usually PCI candidates. A 
post-menopausal woman’s lack of estrogen has a negative effect on function, integrity, and 
arterial structure and can also contribute to bleeding. Patients with low body weight have smaller 
femoral artery diameters, with similar access issues to women (Sajnani & Bogart, 2013).  
Obese patients, despite having more cardiovascular risk factors, have a decreased 
vascular complication risk. This population tends to be younger, and have increased platelet 
aggregation and fibrinolysis related to obesity. Patients with advanced age are at risk for vascular 
complications related to advanced vascular disease and possible local vascular changes. Patients 
with hypertension are at an increased risk of bleeding when the femoral sheath is removed. 
Patients with renal dysfunction are a high risk for vascular complications related to their reduced 
renal excretion of antiplatelets and anticoagulants such as GP IIb/IIIa inhibitors and 
unfractionated heparin (Merriweather & Sulzbach-Hoke, 2012). Diabetics are also at risk for 
vascular complications related to renal dysfunction post-PCI and a pathophysiological response 
to arterial injury that leads to poor outcomes post-PCI (Malviya & Mishra, 2015). 
Vascular Complications. There has been a recent trend within the medical world to 
define bleeding events for consistent research definitions, as many definitions have emerged 
within academic studies (Singh, 2015; Subherwal et al., 2012). Within the literature, the terms 
vascular, bleeding, and puncture site complications, are used interchangeably to describe 
vascular events from slight oozing of blood at the puncture site, hematomas, retroperitoneum 
hematomas, arterial venous (AV) fistulas, and pseudoaneurysms. The terms vascular events, or 
vascular complications, will be used to define the previously listed events found in the literature 







2019; Cowper et al., 2019; Kern et al., 2016; Kim & Zamanian, 2018; Koch et al., 1997; Koch et 
al., 1999; Kobrossi, Tamim, & Dakik, 2014; Levine et al., 2011; Kim et al., 2013; Merriweather 
& Sulzbach-Hoke, 2012; Mohammady et al., 2013; Moser & Riegel, 2008; Rolley et al., 2009; 
Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Singh, 2015; Stouffer & Peter, 2016; 
Subherwal et al., 2012; Tongsai & Thamlikikul, 2012; Walker, Jen, McCosker, & Cleary, 2008; 
Wentworth et al., 2018; Wood et al., 2010). Clinicians can use the National Cardiac Data 
Registry (NCDR) database to calculate PCI bleeding risk (Singh, 2015). The NCDR keeps data 
within the Cath PCI database and defines major bleeding in three categories: bleeding requiring 
hospitalization or blood transfusion, a decrease in hemoglobin greater than 3.0 g/dL, and 
percutaneous entry site hematomas with a major femoral access site bleed or hematoma 
measured at greater than 10 cm (Subherwal et al., 2012). As these definitions are in the medical 
context and do not incorporate all the vascular issues experienced by the clinical nurse, both 
minor and major, the definitions are pulled from a nursing academic textbook that are usually 
used by nurses and taught by cardiovascular nursing experts in Woods et al. (2010) and Moser 
and Riegel (2008).  
There are several types of vascular complications after a PCI that can occur from one to 
12 hours after a procedure. Since there is a large span of hours considered as complication time, 
there is a lack of reporting, which may have led to the lack of evidence and thus few clinical 
practice changes in post-PCI since the 1980s (Moser & Riegel, 2008). These vascular 
complications include slight oozing of external blood, hematomas, retroperitoneal hematomas, 
pseudoaneurysms, arteriovenous (AV) fistulas, and peripheral arterial occlusions (Moser & 
Riegel, 2008; Woods et al., 2010). Although peripheral arterial occlusions are considered a 







complications, no evidence-based studies considered this a complication or recorded instances of 
peripheral arterial occlusions, and thus it was left out of the definition of vascular events within 
this paper (Antonsen et al., 2013; Augustin et al., 2010; Koch et al., 1997; Koch et al., 1999; 
Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et 
al., 2009; Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul, 
2012; Walker et al., 2008; Wentworth et al., 2018).  
External Bleeding. Visible blood loss at the puncture site is Moser and Riegel’s (2008) 
definition of external bleeding. This is the easiest vascular complication to recognize and 
management includes manual pressure or placing a femoral compression device (Moser & 
Riegel, 2008).  
Hematomas. A hematoma is a collection of usually clotted blood that has leaked out into 
the tissues and can be from a venous, arterial, or capillary source (Davis & Shiel, 2019; Moser & 
Riegel, 2008). Symptoms of a localized hematoma include: pain, redness, and swelling (Davis & 
Shiel, 2019). Management of a hematoma varies depending on the size, from comfort measures 
and applying direct pressure. The literature has varying definitions of hematoma size, with 
varying times for intervention (Davis & Shiel, 2019; Moser & Riegel, 2008; Woods et al., 2010). 
Retroperitoneal hematomas. A retroperitoneal hematoma is a hematoma that is caused by 
blood leaking into the retroperitoneum space and can result from puncturing above the inguinal 
ligament with arterial sheath placement. Symptoms include groin and lumber area pain,  
hypotension, drops in hematocrit, and tachycardia. Diagnosis is by computed tomography and 
management involves fluid resuscitation, possible transfusion of blood products, and possible 







 Pseudoaneurysms. A pseudoaneurysm is defined by Woods et al. (2010) as an 
“extraluminal cavity in communication with an adjacent artery, usually the femoral artery and 
vein, which results in a false communication” (p. 546). Signs and symptoms include a pulsating 
mass in the groin, systolic bruit, and pain in the groin with normal distal arterial pulses. Color 
flow imaging and doppler ultrasound are used to confirm. Small pseudoaneurysms usually close 
in four to eight weeks spontaneously, but if they increase in size and hemorrhage, the patients 
will be on long-term anticoagulation. Management includes surgical closure, ultrasound guided 
compression, or ultrasound guided thrombin injections (Woods et al., 2010).  
AV Fistula.  An AV fistula is defined as a channel or communication between a vein and an 
artery and involves both puncture of the vein and the artery resulting in a false communication 
between the two. Signs and symptoms include groin mass with pulsation, decreased temperature 
of the extremity, continuous systolic-diastolic bruit increasing over time, positive thrill at the 
site, and possible ischemia of the extremity. Color flow imaging and doppler ultrasound are used 
to confirm. Management includes surgical repair (Woods et al., 2010).  
Purpose of Inquiry 
Despite the ever-changing landscape of the PCI, bed rest is still necessary after pulling 
the femoral sheath to maintain hemostasis and prevent vascular complications related to the 
trauma of the invasive sheath (Abdollahi et al., 2015). The increased risk for vascular 
complications stems from the adjunct medical therapies of anticoagulants, antiplatelets, and 
direct thrombin inhibitor medications (Moser & Riegel, 2008; Stouffer & Peter, 2016). Moser 
and Riegel (2008) summarize that patients who were traditionally kept on bed rest after a 
femoral access PCI for up to six hours experienced “aggravated preexisting musculoskeletal 







retention (Augustin et al., 2010). Nursing interventions often look to increase patient comfort and 
satisfaction, while preventing complications. Early ambulation has been shown in studies over 
the past two decades to decrease these negative patient outcomes and sometimes lead to same 
day discharges (Moser & Riegel, 2008; Schiks et al., 2008).   
Despite the increase in supportive literature surrounding early ambulation post-femoral 
PCI, traditional practices such prolonged bed rest to prevent vascular complications continue 
within clinical practice (Kim et al., 2013; Rolley et al. 2010; Schiks et al. 2008; Upvall et al., 
2019). This may be due to a lack of “established evidence-based standard” (Kim et al., 2013, p. 
430) within hospital systems (Kim et al., 2013; Woods et al., 2010). The confusion on optimal 
ambulation time post-PCI is evident in the survey conducted by Rolley et al. (2010) of Australian 
and New Zealand cardiovascular nurses on their lived experiences of not only providing PCI 
cares, but the difference between this experience and the literature. The nurses’ responses to the 
question of optimal early ambulation after a femoral access PCI varied from less than one hour to 
greater than eight hours, with nearly half of the nurses selecting four hours (Rolley et al., 2010). 
This finding is in contrast to the literature which notes ambulation after PCIs ranges from two to 
24 hours (Mohammady et al., 2013). This paper seeks to answer if the perception within nursing 
clinical practice, ambulation after four hours of bed rest or less, is supported in the literature and 
to assess if this perception of early ambulation at four hours or less post-PCI has any impact on 
vascular complications (Rolley et al., 2010).  
Research Question  
The research question presented in PICO format (Gray et al., 2017), is as follows: (P) In 







four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O) have 
any impact on a patient’s risk of vascular complications?   
Method of Inquiry  
An integrative review will be used to assess if early ambulation post-PCI has any impact 
on a patient’s risk of vascular complications. According to Whittemore and Knafl (2005), “an 
integrative review is a specific review method that summarizes past empirical or theoretical 
literature to provide a more comprehensive understanding of a particular phenomenon or 
healthcare problem” (para. 1). The integrative review also allows for different review methods, 
such as experimental and non-experimental, to be combined together in order to have a full 
understanding of the issue in question. This type of review allows for a broad range of purposes 
from exploring theories, concept definition, researching methodological issues, and reviewing 
the evidence on a topic. An integrative review was used for this paper to explore the evidence 
behind vascular complication after early ambulation at or less than four hours post-femoral PCI 
(Whittemore & Knafl, 2005). Nursing implications and recommendations are then presented and 
guided by parts of Wagner’s Chronic Care Model (CCM; Rolley et al., 2009; Wagner, Austin, & 
Von Korff, 1996a; Wagner et al., 2001). 
Literature Review 
Introduction to Literature Review  
 This section of the integrative review covers the search strategy used (see Appendix A), 
methods (see Appendix B), appraisal and synthesis, and a conclusion summarizing the seven 
themes found within the literature table (see Appendix C). An in-depth analysis of the three 








Search Strategy  
A thorough literature search was conducted, resulting in 15 articles pertaining to early 
ambulation, decreased time in bed, and addressing how these variables had an effect on vascular 
complications in patients undergoing a post-femoral PCI. As seen in Appendix A, Cochrane, 
CINAHL, ProQuest Nursing & Allied Health Databases, Ovid, PubMed, and the American 
College of Cardiology guideline databases were searched. References of all articles that were 
reviewed were searched; and within CINHAL, articles that used reviewed articles as references 
were also assessed. Keywords used to find relevant articles include cardiac catherization, 
percutaneous coronary intervention, PCI, coronary angiography, percutaneous transluminal 
coronary angioplasty, angioplasty, early ambulation, early mobility, early mobilization, femoral, 
femoral access immobilization, bed rest, guidelines, protocols, practice guidelines, clinical 
practice guidelines, adverse effects, side effects, negative effects, complication, nursing, and 
John X. Rolley. John X. Rolley was used as a keyword as he is an Australian professor who has 
co-authored three of the 15 articles selected. Subject headings used also find relevant articles 
include angioplasty, transluminal percutaneous coronary, and ambulation. Other keywords and 
subject terms can be found in Appendix A.  
Seven articles that were originally chosen that were published after 2009 were ruled out 
because the study’s population consisted of patients who underwent diagnostic coronary 
angiogram and did not include any patients undergoing a PCI (see Appendix A). This is relevant 
because if an intervention, or a PCI, is deemed necessary after the diagnostic coronary 
angiogram is complete, IV anticoagulants, antiplatelet, and direct thrombin inhibitor medications 
are given. These drugs decrease adverse events such as ischemia and thrombus formation at the 







Peter, 2016). Use of anticoagulants, antiplatelet, and direct thrombin inhibitor medications can 
increase a patient’s risk for vascular complications post-PCI by delaying clot formation (Moser 
& Riegel, 2008; Woods et al., 2010). The 15 chosen articles included either PCI or a mixture of 
PCI and coronary diagnostic angiogram patients (Antonsen et al., 2013; Augustin et al., 2010; 
Koch et al., 1997; Koch et al., 1999; Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013; 
Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; Schiks et 
al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018). 
Methods 
 The articles chosen to assess the research question incorporated varying types of research 
methods and had varying levels of evidence (LOE), as scored using Ackley, Swan, Ladwig, and 
Tucker’s (2008) Levels of Evidence in Nursing Research (see Appendix B). The 15 selected 
articles reviewed can be found in the literature tables (see Appendix C), and include three meta-
analyses (Level I; Kim et al., 2013; Mohammady et al., 2013; Tongsai & Thamlikikul, 2012), 
two evidence-based CPGs for PCI (Level I; Levine et al., 2011; Rolley et al., 2011), one 
randomized control trial (RCT; Level II; Augustin et al., 2010), three quasi-experimental studies 
(Level III; Koch et al., 1997; Koch et al., 1999; Walker et al., 2008), one prospective non-
randomized comparative study (Level III; Schiks et al., 2008), one survey (Level VI; Rolley et 
al., 2010), one retrospective cohort study (Level IV; Antonsen et al., 2013), one retrospective 
observational study (Level IV; Kobrossi et al., 2014), one retrospective case study (Level IV; 
Wentworth et al., 2018), and one systematic integrative literature review (Level V; Rolley et al., 
2009).  
  Two tools helped further assess the meta-analyses and evidence-based CPGs. DiCenso, 







et al. (2013; see Appendix D), Mohammady et al. (2013; see Appendix E), and Tongsai & 
Thamlikikul (2012; see Appendix F). The evidence-based CPGs of Levine et al. (2011; see 
Appendix G), and Rolley et al. (2011; see Appendix H), was guided by the Advancing Guideline 
Development, Reporting, and Evaluation in Healthcare [AGREE II] tool (Brouwers et al., 2010).   
Appraisal and Synthesis 
Introduction. The PCI procedure has rapidly evolved from a medical standpoint, yet 
nursing care related to decreasing bed rest or time in bed, and early ambulation has failed to 
evolve at the same pace since the first cardiac interventional procedure was performed by 
Andreas Gruentzig in 1977 (Woods et al., 2010). There is no consensus in the U.S. for cardiac 
bed rest protocols and early ambulation after a femoral sheath PCI from either the nursing or 
medical academic textbooks (Kern et al., 2016; Mann et al., 2019; Moser & Riegel, 2008; Woods 
et al., 2010).  In one academic medical textbook, Mann et al. (2019) recommends patients who 
are undergoing femoral access PCIs require two hours of bed rest if they had a four to six French 
introducer catheter, and three to four hours for a six French or higher introducer catheter. 
However, in clinical practice, ambulation varies according to the hospital policy or device 
protocol (Mann et al., 2019).  
In nursing academic textbooks, Moser and Riegel’s (2008) state that “removal of femoral 
sheaths has become a routine part of the nursing practice” (p. 346). This might explain why there 
is little guidance in the medical literature or academic textbooks. In academic nursing textbooks 
regarding cardiac nursing, there are more in-depth explanations regarding post-procedure cardiac 
care, but no consensus on bed rest protocols after femoral sheath removal and early ambulation. 
(Moser & Riegel, 2008; Wood et al., 2010). An in-depth analysis of the 15 articles revealed 







drawn from the literature include: support for four hours early ambulation post-PCI with low-risk 
study patients, variable definition differences across the literature, methodology heterogeneity of 
the studies, recommended caution from authors when applying results to clinical practice, listed 
risk factors with no support for conclusion or correlation to increased vascular complications at 
early ambulation (Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi et al., 
2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al., 2009; Schiks 
et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018), little 
evidence from CPGs (Levine et. al, 2011; Rolley et al., 2011), and the perceived nursing 
education needs for early ambulation in clinical practice (Rolley et al., 2010).  
Early Ambulation at Four Hours Post-Femoral PCI. The literature supports that 
vascular complications do not increase at early ambulation at less than or at four hours after a 
femoral access PCI, but only in low-risk patients (Antonsen et al., 2013; Augustin et al., 2010; 
Kim et al., 2013; Kobrossi, et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 
2013; Rolley et al., 2009; Schiks et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; 
Wentworth et al., 2018). The low-risk population ranges from excluding patients that had an 
unstable or serious medical condition (Antonsen et al., 2013; Augustin et al., 2010; Schiks et al., 
2008), use of GP IIb/IIIa inhibitors (Antonsen et al., 2013), prior oral anticoagulants (Augustin et 
al., 2010; Koch et al., 1997), pre-or post-low molecular weight heparin or unfractionated heparin 
administration (Augustin et al., 2010; Koch et al., 1999), prior procedure complications 
(Antonsen et al., 2013; Koch et al., 1997; Koch et al., 1999), use of larger catheters (Koch et al., 
1997; Schiks et al., 2008), and vascular complications while on bed rest (Tongsai & Thamlikikul, 
2012; Walker et al., 2008), as seen in Appendix C. Antonsen et al. (2013) notes that careful 







and even lead to same day discharge, resulting in lower costs for the hospital. However, the 
exclusionary indications listed previously are common in patients undergoing a PCI in the acute 
care setting and do not make it easy for nurses to apply the research (Rolley et al., 2009; Rolley 
et al., 2011; Schiks et al., 2008).  
Variable Definition Differences. The second theme observed is varying definitions of 
what time frames comprise early ambulation and vascular complication across the literature 
(Antonsen et al., 2013; Augustin et al., 2010; Koch et al., 1997; Koch et al., 1999; Kobrossi et 
al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et al., 2009; 
Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker 
et al., 2008; Wentworth et al., 2018; Wood et al., 2010). Early ambulation within reported 
literature ranges from one-and-a-half to six hours (Kim et al. 2013). Vascular complications 
varied even greater in definition throughout the literature as bleeding, vascular, or puncture site 
complications (Antonsen et al., 2013; Augustin et al., 2010; Koch et al. 1997; Koch et al., 1999; 
Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et 
al., 2009; Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul, 
2012; Walker et al., 2008; Wentworth et al., 2018; Wood et al., 2010).  
Bleeding definitions ranged from minor to major bleeding (Augustin et al., 2010), 
external bleeding (Wentworth et al., 2018), hemorrhage (Kim et al., 2013), needing further 
compression and bed rest (Koch et al., 1997; Koch et al., 1999; Schiks et al., 2008), or requiring 
a blood transfusion (Antonsen et al., 2013; Kobrossi et al., 2014). Hematomas were the best-
defined vascular complication within the literature and mainly fell under a vascular site 
complication definition as opposed to bleeding or puncture site definition (Antonsen et al., 2013; 







Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008; 
Wentworth et al., 2018). Additional vascular complication definitions include small and large 
hematomas (Augustin et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; 
Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; 
Walker et al., 2008; Wentworth et al., 2018), pseudoaneurysms (Antonsen et al., 2013; Augustin 
et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; 
Schiks et al., 2008; Wentworth et al., 2018), AV fistulas (Antonsen et al., 2013; Koch et al., 
1997; Koch et al., 1999; Mohammady et al., 2013; Schiks et al., 2008; Wentworth et al., 2018), 
retroperitoneal bleeds (Antonsen et al., 2013; Wentworth et al., 2018), and need for vascular 
surgery (Antonsen et al., 2013; Kobrossi et al., 2014; Wentworth et al., 2018). Wentworth et al. 
(2018) and Antonsen et al. (2013), were the only studies to use the NCDR definitions of major 
bleeding in three categories (Subherwal et al., 2012). Wentworth et al. (2018) also compared 
vascular complications noted in the institution’s electronic health record against the NCDR 
definitions of vascular complications. The difference between the electronic health record and 
professional definitions highlight varying definitions of vascular events from the literature, 
professional opinion, and actual clinical practice (Subherwal et al., 2012; Wentworth et al., 
2018). The varying meanings and categories of early ambulation and vascular complications 
create another obstacle in applying the literature’s conclusion that early ambulation is safe for 
patients after a femoral access PCI (Mohammady et al., 2013; Schiks et al., 2008).  
Methodology Heterogeneity. The third theme noted in Appendix C is methodology 
heterogeneity throughout the studies. In addition to excluding high-risk populations, the studies 
differed in their inclusion characteristics, study selection, study designs, measures, protocols, 







different statistical models, and collecting different types of reported baseline characteristics 
(Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi, et al., 2014; Koch et al., 
1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al., 2009; Schiks et al., 2008; 
Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018). Although the 15 
independent studies, find that the risk for vascular complication does not increase post-femoral 
access PCI with early ambulation, the heterogeneity of the studies makes it hard to draw a 
collective conclusion for application to a realistic clinical situation (Mohammady et al., 2013; 
Schiks et al., 2008).   
Clinical Practice Caution. The highest LOE from Kim et al. (2013), Mohammady et al. 
(2013), and Tongsai and Thamlikikul, (2012), supports early ambulation after a femoral PCI, but 
urges caution in interpreting results accounting for patient and procedural risk factors, varying 
clinical practices, and methodological flaws. Kim et al. (2013) and Mohammady et al.(2013), 
recommend caution in broadly applying study results, and that nurses must take evidence-based 
risk factors such sheath size, age, gender, hemostatis technique, and type of adjunctive therapy 
used into consideration when making clinical decisions for early ambulation. Varying clinical 
practices in the study protocol is observed across all of the experimental and observational 
design studies (Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al., 
1997; Koch et al., 1999; Schiks et al., 2008; Walker et al., 2008;Wentworth et al., 2018), that 
incorporate or exclude many of the risk factors listed by Kim et al. (2013) and Mohammady et 
al. (2013), making it hard to compare or tease out vascular risk factors within studies (Antonsen 
et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al. 1997; Koch et al., 1999; Kim 
et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker 







studies in Mohammady et al. (2013), and bias is evident in all three meta-analyses, which also 
decreases the generalizability of the results (Kim et al., 2013; Mohammady et al., 2013; Tongsai 
& Thamlikikul, 2012).  
Vascular Risk Factor Conclusions in the Literature A fifth theme is the lack of 
evidence to show a relationship between vascular complications and patient populations who are 
at risk for these types of complications. Within the literature reviewed in Appendix C, baseline 
characteristics that are also risk factors are listed and include activated clotting levels, activated 
partial thrombin levels (Augustin et al., 2010; Wentworth et al., 2018), female gender, body mass 
index, low body weight, advanced age, use of anticoagulants, large catheter size, length of time 
the catheter is in place, and underlying peripheral vascular disease (Augustin et al., 2010; 
Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et 
al. 2009; Schiks et al., 2008; Walker et al., 2008). Wentworth et al. (2018) determined with 
statistical significance that patients with vascular risk factors had an increase in vascular 
complications. Wentworth et al. (2018) found an increase in vascular complications in patients 
who received GP IIb/IIIa inhibitors and higher mean activated clotting levels at removal of the 
sheath and closure of the site. However, since no correlation coefficient is listed, there is a 
difference, but not a relationship between these variables. Making decisions regarding early 
ambulation is difficult when the majority of the literature does not concur on the 
recommendation for patients with increased vascular risk factors (Augustin et al., 2010; Kobrossi 
et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al. 2009; 
Schiks et al., 2008; Walker et al., 2008). This conclusion is further confounded by Kim et al. 







gender, age, adjunctive therapies, and hemostatis need to be considered when applying these 
results to clinical practice (Kim et al., 2013; Mohammady et al., 2013).  
Little Evidence from CPGs. The sixth theme that the literature revealed is that CPGs 
provide either no evidence (medical) or low-evidence (nursing) for early ambulation after a 
femoral access PCI. Both guidelines were graded using the AGREE II tool in the context of the 
research question (Brouwers et al., 2010;  Levine et al., 2011; Rolley et al., 2011). The medical 
guidelines of Levine et al., (2011), see Appendix C and G, were quite specific to the medical 
aspects of the procedure, but only indirectly address early ambulation in the context of 
adjunctive therapies and vascular compression devices. The evidence-based CPGs from Rolley et 
al. (2011) for Australian and New Zealand cardiovascular nurses are specific to PCI nursing 
cares and address a gap in both the nursing and medical literature related to care of patients 
undergoing a PCI (see Appendix C and H). Rolley et al. (2011) addresses early ambulation 
within the CPGs, but the evidence is low per the grading system for evidence & 
recommendation. Per Rolley et al. (2011), this may be related to chosen study methodology 
heterogeneity, populations chosen, hemostatis methods, adjunctive therapies, multiple 
procedures within studies, and varying heparization protocols. In addition, a clear audit of why 
studies were chosen was not clear within either guideline. Both  guidelines provide valuable 
information about the PCI, but they lack high quality evidence to support early ambulation after 
a femoral access PCI (Levine et al., 2011; Rolley et al., 2011).   
Perceived Nursing Needs in Clinical Practice. Finally, nursing care post-PCI related to 
bed rest and early ambulation varies greatly and there is a perceived need for more education. 
Rolley et al. (2010) conducted a survey asking cardiovascular nurses about nursing care of 







(see Appendix C). When surveyed about the proper time to initiate ambulation after a PCI, the 
majority of nurses selected four hours after a PCI (46.4%), followed by three hours (10.9%), and 
two hours (10.9%). The remaining 32% of nurses answered from less than one hour to greater 
than eight hours as optimal ambulation time. This can also be reflected in the nurses’ perceived 
need for more information on post-PCI procedure complication monitoring and time to 
ambulation post-PCI sheath removal. Nurses also rated the time to ambulation post-PCI as 
lacking in high LOE within their practice and perceived a statistically significant difference in 
the priority of monitoring post-procedure complications and what actually happened in clinical 
practice (Rolley et al., 2010). Although this is one study and has methodological flaws (lower 
LOE and possible responder bias), Rolley et al., (2010), like Wentworth et al. (2018), points out 
a different understanding of the PCI procedure and early ambulation post-procedure from the 
nursing perspective and that there is a lack of consistent evidence and standards for nursing to 
turn to within the literature to find these answers.  
Conclusion. The literature reveals that early ambulation at or before four hours  
post-femoral access PCI does not increase vascular complications as compared to later 
ambulation in low-risk patients. The results should be used with caution in clinical practice, 
considering the differences in definitions of variables, known risk factors to increase 
complications, varying clinical practices, methodological flaws of studies, and that these studies 
acknowledge potential risk factors, but do not find any major differences or can support a 
relationship between the risk factor variables and the increase risk of vascular complications 
(Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al. 1997; Koch et al., 
1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 







evidence-based CPGs for PCIs, but these guidelines fall short in addressing ambulation post-PCI 
(Levine et al., 2011; see Appendix G), and provide low quality evidence to support early 
ambulation in the nursing guidelines with no clear trail of why studies were selected (Rolley et 
al., 2011; See Appendix H). Finally, although it is only one study, the novel survey by Rolley et 
al. (2010), assesses cardiovascular nurses’ perceptions of post-femoral access PCI care and the 
difference in perception of early ambulation. The current evidence suggests that nurses who care 
for patients undergoing PCI need education on assessing patients for risk factors which could 
increase their risk for post-PCI complications (Rolley et al. 2010).  Additionally, nurses would 
benefit from a guideline that assists them in applying the evidence to all patients, not just those 
without risk factors (Levine et al., 2011; Rolley et al., 2011).   
Chronic Care Model 
The CCM, was first introduced in the 1990s by Wagner et al., (1996a), with support of 
the Robert Woods Johnson Foundation to improve outcomes for patients with chronic disease 
(Wagner et al., 1996a; Wagner et al., 2001). The globally recognized CCM looks to provide 
evidence-based and patient-centered care within a proactive framework for healthcare systems to 
improve delivery and outcomes to chronic care populations (Yeoh et al., 2018). The community 
and the healthcare system within the model have several different groups that enable better 
chronic care. These two groups are intertwined, as the community incorporates and is linked to 
the healthcare system (Wagner et al., 2001). Within the community there are resources and 
policies, that ultimately influence the groups within the healthcare system. Within the healthcare 
system there are the groups of self-management, delivery system designs, decision support, and 
clinical information support (CIS). Together, motivated and well-informed patients, along with 







elements from this model that aid addressing how this research can be applied into nursing 
clinical practice can be seen in the healthcare system elements of decision support and CIS 
(Wagner et al., 2001).  
Decision support refers to providing the best care every time to all patients (Wagner et 
al., 2001; Yeoh et al., 2018). The decision support tool includes evidence-based guidelines to 
guide care. Although Wagner, Austin, and Von Korff (1996b) state there is sometimes push back 
around homogenized care that does not look at the unique and individualized needs of the 
patient, this “rugged individualism leads to practice variations and failure to adhere to 
guidelines” (Wagner et al., 1996b, p. 519).  However, guidelines can only be considered useful 
and lead to outcome and process improvements if they are credible, relevant, and well-integrated 
into a comprehensive practice improvement intervention and into patient care (Wagner et al., 
1996a). A possible way to integrate decision support tools into practice is to place them into the 
clinical information systems (CIS). Decision support tools cannot be discussed without 
reviewing the CIS element, as these are also based on evidence-based guidelines (Wagner et al., 
2001).  
CIS provide the ability to capture and integrate critical information into patient care and 
also help clinicians remember to provide evidence-based care (Wagner et al., 2001; Yeoh et al., 
2018). In addition to serving as a reminder for evidence-based guidelines for clinicians, CIS can 
serve as a registry for managing population health and providing feedback on quality of care 
(Yeoh et al., 2018). The CCM can guide the approach for standardizing a post-PCI ambulation 
protocol by incorporating CPGs throughout the CIS in the form of flow sheets, patient 








Conclusion, Recommendations, and Nursing Implications  
Introduction 
The primary purpose of this integrative literature review is to examine recommendations 
for ambulation post-PCI. Although PCI is a common procedure routinely performed in the acute 
care setting, nurses continue to follow bed rest protocols which have been in place for many 
years (Augustin et al., 2010; Kim et al., 2013; Rolley et al., 2010; Schiks et al.,  2008). This 
section will cover conclusions related to early ambulation post-PCI based on the current 
evidence, discuss the implications for nursing practice, as well as provide recommendations for 
medical and nursing healthcare providers who care for patients who require a PCI. 
Conclusion 
This integrative review addresses if early ambulation at or less than four hours post-
femoral access PCI, based on general nursing perception of early ambulation (Rolley et al., 
2010), has any impact on a patient’s risk of vascular complications. This review used a rigorous 
search strategy to find all relevant literature that addressed early ambulation at or less than four 
hours post-PCI. In addition to articles yielded from key terms, all references of reviewed articles 
were assessed, all articles referencing reviewed articles in CINHAL were assessed, and a 
reassessment of each article was undertaken to assess if the study population included patients 
undergoing a PCI and was not limited to cardiac catherization patients (see Appendix A). This 
strategy produced 15 articles for the literature review and includes three meta-analyses (Kim et 
al., 2013; Mohammady et al., 2013; Tongsai & Thamlikikul, 2012), two evidence-based CPGs 
for PCI (Levine et al., 2011; Rolley et al., 2011), one RCT (Augustin et al., 2010), three quasi-
experimental studies (Koch et al., 1997; Koch et al., 1999; Walker et al., 2008), one prospective 







retrospective cohort study (Antonsen et al., 2013), one retrospective observational study 
(Kobrossi et al., 2014), one retrospective case study (Wentworth et al., 2018), and one systematic 
integrative literature review (Rolley et al., 2009).  
The review found that the literature, especially the three meta-analyses that are the 
strongest LOE (Kim et al., 2013; Mohammady et al., 2013; Tongsai & Thamlikitkul, 2012), 
answered the research question that early ambulation at four-hour post-femoral PCI does not 
increase vascular complications, but only in low-risk patients (Antonsen et al., 2013; Augustin et 
al., 2010; Kim et al., 2013; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Levine et. 
al, 2011; Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; 
Schiks et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018). 
This review also showed that before applying these results to clinical practice, the clinical nurse 
needs to consider several factors. The clinical nurse needs to consider a patient’s baseline risk 
and procedural factors that may increase a patient’s risk of vascular complications during early 
ambulation. The answer to this clinical question is further complicated by gaps in literature 
including different definitions of variables, heterogeneity within the studies’ methodology  
(Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et 
al., 1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & 
Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018), and little guidance from CPGs 
(Levine et al., 2011; Rolley et al., 2011). 
Nursing Implications 
Implications for nursing from this integrative review first confirm that the nursing 
perception of optimal ambulation time for patients post-femoral PCI of four hours or less, is 







2013; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Levine et. al, 2011; 
Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; Schiks et 
al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018). Second, 
this review can be used to urge nurse leaders to ensure nurses working in the acute care setting 
who care for patients that undergo a PCI receive updated evidence-based education on post-
procedural care and how to safely apply evidence into clinical practice (Kim et al., 2013; Rolley 
et al., 2010). Third, this review calls for the development of CPGs for nursing care post-PCI, that 
can be applied to all patients, not just those with a low-risk for complications (Mohammady et 
al., 2013; Rolley et al., 2009; Rolley et al., 2010, Rolley et al., 2011).  
Nurses play an invaluable role following PCIs by monitoring for vascular complications 
post-procedure (Moser & Riegel, 2008; Woods et al., 2010), yet often are not aware of the 
evidence-based literature supporting early ambulation (Tongsai & Tahamlikitkul, 2012), leading 
to sacred cow practices such as prolonged bed rest (Abdollahi et al., 2015; Rolley et al., 2010; 
Upvall, et al., 2019). Nurses have indicated that education on post-PCI procedure complication 
monitoring and time to ambulation after removing the arterial sheath as high educational 
priorities (Rolley et al, 2010). Clinical nurses should also be educated on recognition of the risk 
factors for vascular complications in order to individualize which patients may not be candidates 
for early ambulation at four hours (Antonsen et al., 2013; Kim et al., 2013; Mohammady et al., 
2013; Rolley et al., 2010; Tongsai & Thamlikitkul, 2012).  
Evidence-based CPGs for PCI care have been written by Australian and New Zealand 
nurses (Rolley et al., 2011), but none have been written for American nurses. American nurses 
can access general information about a PCI from Levine et al. (2011), however, the guide does 







for future guidelines that address post-procedural care within the U.S. As the number of PCI 
procedures increase, so will vascular complications (Kim & Zamanian, 2018). CPGs help 
standardize practice and provide guidance using the latest evidence, in order to avoid sacred 
cows within clinical practice (Rolley et al., 2011; Wagner et al.,1996b; Upvall, et al., 2019).  
Recommendations  
There are several recommendations from this study. The first recommendation includes 
implementing early ambulation at four hours post-femoral access PCI into clinical practice after 
a thorough review of a patient’s baseline risk factors and procedural factors that may increase 
vascular complications (Antonsen et al., 2013; Kim et al., 2013; Mohammady et al., 2013; 
Schiks et al., 2008). The second recommendation is a need to educate nurses on the evidence-
based literature to support early ambulation and monitoring for complications (Rolley et al., 
2010). The third recommendation is to address the gaps in the literature by standardizing 
vascular definitions within the literature (Singh, 2015). The fourth recommendation is to publish 
a RCT in a controlled research environment in order to further standardize results and potentially 
draw conclusions about relationships between vascular risk factors, early ambulation, and 
vascular complications (Kim et al., 2013;Wentworth et al., 2018). Finally, evidence-based CPGs 
should be revised on a routine basis to keep up with the advances in procedural care, technology, 
medications, and procedural technique (Levine et al., 2011; Rolley et al., 2011).  
Evidence-based CPGs on post-procedural PCI care are needed to provide safe clinical 
nursing care within the U.S. In order to be successful, evidence-based guidelines can be well-
integrated into clinical practice and patient care (Wagner, 1996a; Wagner et al., 2001). Using 
Wagner’s CCM, evidence-based CPGs, or decision support tools, safe post-PCI nursing care can 







health record (Levine et al., 2011;Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; 
Wagner et al., 1996a; Wagner et al., 2001; Yeoh et al., 2018). The guidelines can be integrated 
into patient assessment tools and flow sheets that identify risk factors, types of vascular 
complications, and how to assess for vascular complications in patients undergoing PCIs. 
Clinical pathways that promote early ambulation for low-risk patients can help nurses make 
timely and evidence-based decisions that can improve the quality of patient care and even 
decrease overall costs of the PCI (Rolley et al., 2009; Wagner et al., 1996a; Wagner et al., 2001; 
Yeoh et al., 2018).  
Final Summary  
 Despite the increase in radial access PCIs in the U.S., femoral access remains the most 
popular access site for patients undergoing a PCI (Stouffer & Peter, 2016). Patients undergoing 
femoral access PCIs deserve optimal, evidence-based care from both the medical and nursing 
fields, yet there are barriers to delivering this care in the form of separate evidence-based 
guidelines and differing opinions of optimal care (Levine et al., 2011; Rolley et al., 2011). This 
integrative review sought to determine if early ambulation at or less than four hours post-femoral 
access PCI, based on general nursing perception of early ambulation (Rolley et al., 2010), had 
any impact on a patient’s risk of vascular complications. This review used 15 articles (see 
Appendix C), found via a rigorous search with varying LOE as defined by Ackley et al. (2008) in 
Appendix B. The review found that even the highest LOE (Kim et al., 2013; Mohammady et al., 
2014; Tongsai & Thamlikitkul, 2012), supported early ambulation at less than four hours post-
PCI did not increase a patient’s risk of vascular complication, but only in low-risk patients. 
Before applying these findings to clinical practice, the clinical nurse may need to access other 







affect them as a candidate for early ambulation. In addition to these considerations, several other 
gaps were identified in the literature including different definitions of variables, heterogeneity 
within the studies’ methodology, (Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 
2014; Koch et al., 1997; Koch et al., 1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et 
al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018), and little 
guidance from CPGs (Levine et al., 2011; Rolley et al., 2011).  
 The first nursing implication from this integrative review confirms that the majority of 
nurses’ perception of optimal ambulation time, of four hours post-femoral access PCI, based on 
Rolley et al.’s (2010) survey is supported by evidence from the literature. Rolley et al. (2010) has 
shown that there is variation in nursing clinical practice related to PCI care and there is a need 
for more nursing education and higher levels of evidence to support post-procedural PCI care. 
The second and third nursing implications include updated evidence-based education on PCI 
cares and how to safely apply this evidence to clinical practice (Rolley et al., 2010). The final 
nursing implication includes a call for an evidence-based CPGs for nursing care post-PCI 
(Rolley et al., 2011).  
Recommendations from this integrative review include more research to fill gaps in the 
literature such as variable definitions, conducting higher LOE research to support early 
ambulation, education for clinical nurses, and using the CCM to integrate evidence-based 
literature in the form of clinical pathways and patient assessment tools into the electronic health 
record (Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi, et al., 2014; 
Koch et al., 1997; Koch et al., 1999; Levine et al., 2011; Mohammady et al., 2014; Schiks et al., 







Wagner, Austin, & Von Korff, 1996a; Wagner et al., 2001;Walker et al., 2008; Wentworth et al., 
2018).  
As the number of PCIs continue to grow (Kim & Zamanian, 2018), more emphasis 
should include the quality of the nursing care for patients undergoing a femoral access PCI. 
There is evidence to debunk sacred cow nursing practices such as prolonged bed rest and support 
early ambulation, which not only improves patient comfort, but could also have favorable 
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Appendix  B 
Ackley, Swan, Ladwig, & Tucker’s Levels of Evidence in Nursing Research 
Level of evidence (LOE) Description 
Level I Evidence from a systematic review or meta-analysis of all relevant RCTs 
(randomized controlled trial) or evidence-based clinical practice guidelines based 
on systematic reviews of RCTs or three or more RCTs of good quality that have 
similar results.  
Level II Evidence obtained from at least one well-designed RCT (e.g. large multi-site 
RCT). 
Level III Evidence obtained from well-designed controlled trials without randomization (i.e. 
quasi-experimental). 
Level IV Evidence from well-designed case-control or cohort studies. 
Level V Evidence from systematic reviews of descriptive and qualitative studies (meta-
synthesis). 
Level VI Evidence from a single descriptive or qualitative study. 
Level VII Evidence from the opinion of authorities and/or reports of expert committees. 
  
 
Note. Reprinted from “Evidence-based nursing care guidelines: Medical-surgical interventions,” by B.J., Ackley, B.A. Swan, G.B., 
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ambulation range from one-
and-a half to four hours.  
-Six studies conducted 
prior to 1990 had early 
ambulation at two-and-a 











model, there is no 
increase in 
vascular events at 
the puncture site 
r/t to early vs. late 
ambulation post-






gender, age, & 
hemostasis 
techniques when 
applying results.  
-Weaknesses 
include a low 
powered test, to 
assess publication 
bias, no other 
heterogeneity 
tests, & including 
studies that define 
early ambulation 








undergoing a  
post-femoral 
access PCI. 

















to six hrs, 
because it 
systematically 
































Tamim, H., & 
Dakik, H. A. 
(2014). Vascular 
complications of 
early (3 H) vs 






























time of six 
hours post 
CC & PCI 
is safe.  
-Patients 
undergoing a CC 





and/or PCI with 
either a five or six 
French arterial 
sheath (n = 262). 
Exclusions:  





















observational study  
-All procedures 




fellow pulling AS. If only 
a CC, AS was removed, 
& 15 mins of manual 
hemostasis. For a PCI, 
the sheath was removed 
three to four hours after 
procedure w/15 minutes 
of manual compression. 
Patients stayed 24 hours 
post-procedure. 
Ambulation per group.  
EA: Three hrs (n = 147) 
LA: Six hrs (n = 115) 
Variables/Measures: 
TIB, ambulation time, & 
vascular complications 
(bleeding, hematoma, & 
PAS) 
Instruments:  
Large Hematoma: > five 
cm by five cms  






Descriptive & Chi 
squared statistics (x2), & 
t-test 
Baseline Characteristics 
EA # (%) vs. LA # (%):  
Anticoagulation: 
LMWH: 0 vs 5 (4.3),  
p < 0.01 
Warfarin: 0 vs. 3(2.6%),  
p = 0.05 
Six Fr AS: 128 (87) vs. 114 
(99), p < 0.001 
-No difference in gender, 
age, & BMI.  
-Most patients undergoing 
PCI were in the LA group 
(21%) vs. the EA group 
(4.5%).  
Vascular Complications 
EA # (%) vs. LA # (%): 
PAS:1 (0.7) vs. 1 (0.9),  
p = 0.97 
Any Hematoma: 
3 (2.0) vs. 2(1.7),  
p = 0.97 
Large Hematoma: 
2 (1.4) vs. 2 (1.7),  
p = 0.96 
-No hematomas after 
ambulation, only after 
sheath pull.  
Overall Vascular 
Complication Rates:  
2.7 % vs. 2.6 %,  





three hrs vs. six 
hrs in vascular 
complications 
after a femoral 
CC/PCI. 
-Larger sheaths & 
more 
anticoagulation 






lower LOE & 
non-randomized 











possible bias from 
having one MD 
performing the 
PCI, & low PCI 
representation in 
the early 
ambulation group.    
-Changing 
from a six hr 








receiving a CC 
with or without 





(sheath size & 
anticoagulation
) did not 
increase the 
complications 
within the EA. 
-Study limited 


































Koch, K.T., Piek, 
J.J., de Winter, 
R.J., Mulder, K., 
David, G.K., Lie, 














































procedure.   
 
-Elective CA 
using six Fr AS 
via the femoral 












IV heparin prior 
to procedure,  
preexisting 
hematoma after 
recent CC, stent 
types needing 
larger catheter for 
placement,  
requiring larger 
catheter size, & 
continuation of 






w/Aspirin (100 mg). Six 
Fr AS used in procedures 
w/a 5,000 IUs heparin IV 
(2,500 IUs given if the 
procedure was > 90 
mins). AS was removed 
immediately, manual 
compression was applied, 
& maintained w/a 
compression bandage. 
Supine TIB until 
ambulation.  
IG: Four hrs (n = 420)  
CG: Next morning 
(n = 410) 
Variables/Measures: 
TIB, early ambulation, & 
puncture site & vascular 
complications (bleeding 
at or during ambulation 
or PSC 48 hours post-
PCI) 
Instruments:  
Bleeding: Further  
compression & bed rest 
PSC: Groin hematoma > 
five by five cms, PAS, & 
AV fistula confirmed by 
ultrasound  
Statistical Analysis: 
Descriptive statistics  
Baseline Characteristics 
IG vs. CG:  
Mean Age (SD):60 years 
old (15.6 years) vs. 61 
years old (11 years) 
Men # (%): 312 (74) vs. 
295 (72) 
Mean Weight (SD): 81 kg 
(9.3 kg) vs.79 kg (8.1 kg) 
Hemostasis Time (SD):  
n = 9.6 mins (2.5 mins) vs. 
9.9 mins (2.6 mins) 
Bleeding/Vascular Events 
IG  # (%) vs. CG # (%):  
All bleeding events:  
10 (2.3) vs. 9 (2.2) 
Bleeding before 
Ambulation: 1 vs. 1 
Bleeding after Ambulation: 
3 vs. 0  
Late Bleeding > 48 hours: 
1 vs. 1  
Hematoma: 4 vs. 5 
AV Fistula: 0 vs.1  
False aneurysm: 1 vs.1  
-Two patients did not 
ambulate in IG, one r/t to 
bleeding throughout bed 
rest & one r/t to a 
hematoma > five cms when 
compression bandage 
removed.  





dose heparin via 
femoral route is 






hospital stay.  
-Weaknesses of 














does not allow the 
authors to 
generalize beyond 
the study, but 
describe patterns 





PCI  may be 
able to 
ambulate four 
hours vs.  
overnight after 













needed to infer 







































Koch, K.T., Piek, 
J.J., de Winter 
R.J., Mulder K., 
Schotborgh, C.E., 
Tijssen, J.G.P, … 





stenting with 6 F 
guiding catheters 
and low dose 
heparin. Heart, 81

































48 hours  
of the 
procedure.   
 
 
-Elective CA vis 
the femoral 
approach using 







procedures at the 
facility (n = 300).  
Exclusions: Prior 
to procedure was 











procedures.   
-Quasi-experimental 
group w/no control group 
or randomization.  
-Pretreatment w/Aspirin 
(100 mg). Six Fr AS for 
procedures performed 
w/a 5,000 IU heparin IV 
(2,500 IU given if the 
procedure was > 90 
mins). AS was removed 
immediately, manual 
compression was applied, 
& maintained w/a 
compression bandage. 
Two hrs supine bed rest.  
IG: Ambulation at two 
hours post-op (n = 300) 
Variables/Measures: 
TIB, early ambulation, 
PSC, & vascular 
complications (bleeding 
at or during ambulation 




compression & bed rest. 
PSC: Groin hematoma >  
five by five cms, PAS, & 
AV fistula confirmed by 
ultrasound.  
Statistical Analysis: 
Descriptive statistics  
Baseline characteristics 
(% of participants): 
Mean Age: 60 years old 
(10.7%) 
Men # : 237 (80%) 
Mean Weight:79 kgs 
(12.3%) 
Patients treated 
w/additional Heparin #: 12 
(4%)  
Time to hemostasis: 9.6 
mins (3.2%) 
Bleeding at Ambulation:  
-5 patients (1.7% of 
participants) 
-Three patients had balloon 
angioplasty & two had stent 
placement.  
-Two patients ambulated 
later than two hours, three 
patients at four hours, & 
two patients after an 
overnight bed rest.  
48 Hour Puncture Site 
F/U # (%):  
Late bleeding: 0 
Hematoma: 9 (3%) 
-Six patients w/hematomas 
had balloon angioplasty & 
three w/hematomas had 
stent placement.  
AV Fistula: 0 








dose heparin via 
the femoral route 
is safe with low 
rates of puncture 
site complications 
and bleeding.  
-Weakness of 
study include the 
descriptive 
statistical method 
used, lack of a 
control group, 




& low-risk patient 
selection. 
-The descriptive 
statistics as the 
statistical analysis 
does not allow the 
authors to 
generalized 
beyond the study, 
but describe 







PCI were able 
to ambulate 
two hours after 
AS pull w/a 
low heparin 
dose.  




analysis, & a 
realistic 
population  
will be needed 


























































force on practice 





Journal of the 
American College 





















for PCIs.  
 
  
-CPGs for North 
American adult 
patients 















trials research in 
health services;  
& members of 
AHA, SCAI, & 
ACCF.   
Inclusion:  
English language 













outcomes; quality & 




Review Tool: Class of 
Recommendations and 





Guideline Review Tool: 
AGREE II score of 80% 
to be considered high 
quality guidelines to 
guide the PICO question 
& intervention.   
-The key terms ambulation, 
early ambulation, & 
decreased bed rest, were 
searched throughout the 
document w/no sections on 
the topic & only a small 
amount of indirect 
references to the 
intervention through 
sections on adjunctive 
therapies & VCDs.  
-Early ambulation is only 
mentioned in reference to 
VCDs  (Class IIa, LOE B).  
-Routine VCDs do not 
decrease vascular 
complications (Class III, 
LOE B).  
AGREE II:  
Domain 1: 67% 
Domain 2: 27% 
Domain 3: 58% 
Domain 4: 28% 
Domain 5: 46%  
Domain 6: 100% 
Overall Quality r/t PICO 
question: Poor to fair  
Use? Yes, with major 
modification.  
- See Appendix G 
for AGREE II 
scores. 
-The first CPG 
for PCIs, but no 
guidance on early 
ambulation, TIB 
or data regarding 
vascular 
complications r/t 
early ambulation.  
-The CPGs were 
broad in scope & 
purpose, but more 
specific to 
medical aspects 




low at 28% & 
46% r/t to the 
PICO question.   
-The ability to 
replicate is not 
easy to follow, 
leading to a score 
of 67% in rigor of 
development. 
-The CPGs 
should be revised 
w/major 
modifications & 
input from all 
professional 
involved. 




data on the risk 
of vascular 
complications 
w/in the PCI 




















































Atoof, F., Sari, A. 
A., & Zolfaghari, 
M. (2013). Bed 






































retention.    
-5,857 articles 




up to May 2012  
(n = 1,115).  
Inclusion: 18+,  
receiving PCI, 
any sheath size, or 
hemostasis 





















review & meta-analysis 
Variables/Measures: 
TIB, ambulation times, & 
vascular complications  
(hematomas, bleeding, 
PAS & AV fistulas) 
Timeframe Groups:  
G1: Two-four hours vs. 
six hours of bed rest 
G2: Four to six hours vs. 
eight hours of bed rest 
G3: Three vs. 10 hours of 




Collaboration Risk of 
Bias Assessment Tool  
Heterogeneity:  
Chi-square statistics (x2),  
p  > 0.10,, & measures of 
inconsistency, I 2 <  50% 
Statistical Analysis:  
Effect size: OR 
Outcomes:  
Mantel-Haenszel & 
Forest plots  
Bias: All studies had 
methodological flaws & 
80% of the studies had an 
unclear risk of bias.  
Measures &  
Heterogeneity (H):  
Two-Four vs. Six hrs: 
Hematomas: Z = 0.33,  
p = 0.74, H: x2 = 0.01, 
p = 0.94, I 2 = 0  
Bleeding: Z = 0.08, p = 
0.93, H: x2  = 0.07, p = 0.79, 
I 2 = 0  
PAS: Z = 0.26, p = 0.79,  
H: Vlasic et al. (2001) only 
AV Fistula: N/A, no events 
in Vlasic et al. (2001)  
Three vs. 10 Hours:  
Hematoma: Z = 0.01, p = 
0.99, H: Augustin et al. 
(2010) only 
Bleeding: Z = 0.97, p=0.33, 
H: Augustin et al. (2010) 
only 
PAS: Z = 0.69, p = 0.49,  
H: Augustin et al. (2010) 
only  







Tool used, see 
Appendix E.  
-Assuming a 
fixed-effect 
model, there is no 
significant effects 
on the incidences 
of hematoma 
formation, 
bleeding, PAS, & 




results r/t sample 
size, definition of 





bias risk, & lack 
of consistent f/u 




it is still a high 
LOE for short 
TIB, & early 
ambulation after a 










& AV fistulas.  
-Continue to 
assess varied 









other flaws in 
methodology.   
-Although not 
stated by 
authors, it is 































Rolley, J. X., 
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Fernandez, R., & 
Dennison, C. R. 
(2009). Review of 

















Nursing & Allied 























-Selected or # of 
articles not listed. 
Inclusion: CPGs 








or nursing care 
related to PCIs &   
published in 
English.   
Exclusion: Not r/t 













literature review  
Framework & Model:  
-Conceptual framework 
of the patient journey.   
-Focus on post-PCI 
(monitoring, groin care, 
sheath removal, 
ambulation, & 
management of PCI 
complications).  
Wagner’s  
Chronic Care Model:  
-Model is person-
centered & outcome 
approach focused.  
-Elements from model 
used include: patient & 
family’s needs are the 
focus of care; self-
management empowers 
patients to better their 
own health; skilled 
clinicians &  
evidence-based educated 
patients can collaborate;   
decision-support tools 
can help clinicians 
provide evidence-based 
care; supportive policies 
can inform care delivery;  
& computer information 
systems can enhance care 





-RF for vascular access site 
complications include age, 
gender, weight, AS size, 
AS dwelling time, 
anticoagulation therapy, & 
PCI vs. CC or CA.  
Sheath Removal: 
-Limited literature  
w/methodological 
heterogeneity & small 
sample size (in studies 
looking at skills, training, 
evidence to guide AS 
removal), & policies that 
minimize vascular 
complications.  
Hemostatis Method: No 
difference in studies 
between methods.  
Early Ambulation: 
-Limited consensus & 
consistency 
-Even w/TIB shortened to 
two hours, there is limited 
evidence for vascular & 
access site complications.  
-Evidence-based 




cares r/t PCI 
needed due to the 
lack of guidance 
in the medical 
literature.  
-During post-PCI 
cares, nurses need 
to be aware a 
patient’s RF for 
vascular  
complications. 
-TIB at two hours 
shows little risk 
for vascular site 
complications. 










study is essential 
in identifying a 
gap in the 
literature r/t 
nursing care of 
the patient 
undergoing a PCI.  



























































































































.   
-RNs w/an 
average of 12.3 
years of 
experience 
working in the 
CV setting  
(n = 148), only 
110 RNs finished 
the survey from 
March 2008- 
2009.  

















survey, & anyone 





- Prior survey from 
consensus conference of 
CV experts & literature 
review informed current 
survey.  
-Twelve CV experts 
evaluated survey prior to 
a pilot test.  
Measures: Ambulation 
time, CPS (what is 
optimal practice & what 
actually happens), HDV 
(perception of LOE to 
support nursing cares), & 






response & snowballing 
effect  
Sections: 
Categorical or 10-point 
Likert item scale 
Internal Consistency: 
Cronbach’s alpha  
HDV/Ambulation Time/ 




CPS:  n = 6 (.65) 
HDV: n = 16 (.88) 
Knowledge & Capacity:  
n = 14 (.89) 
Optimal ambulation time 
Post-PCI in hrs: 
< One: n = 1 (0.9%) 
One: n = 3 (2.7%) 
Two: n = 12(10.9) 
Three: n = 12 (10.9%) 
Four: n = 51 (46.4%) 
Five: n = 2 (1.8%) 
Six: n = 17 (15.5%) 
Seven: n = 9 (8.2%)  
> Eight: n = 3 (2.7%)  
CPS:  
 Monitoring  
Groin Post-PCI: n = 110,  
p = 0.002 
HDV:  
Time to Ambulation Post-
PCI:  
-Ranked #9 (ranked low) 
- 6.22 +/- 2.52 (n = 115) 
Education Needs: 
 Post-PCI Procedure 
Complication Monitoring: -
-Ranked #3 (high need) 
-4.13 +/-2.95 (n=115) 
Time to ambulation post-
PCI sheath removal: 
-Ranked #4 (high need) 
-4.12 +/- 2.81(n = 115) 
-Internal 
consistency fair to 
good.   
-Average 
perceived time for 
ambulation post-








ranked low LOE 
to support time to 
ambulation at 















statistics usage.  
-This study 
addresses a gap 
both nursing & 














time per RN 
perception is 
four hours. 
-RNs rated the 
perceived LOE 
for ambulation 
as low & 


























Objectives  Study 
Population/ 
Sample/Setting 












Rolley, J. X., 
Salamonson, Y., 
Wensley, C., 
Dennison, C. R., 







































-CPGs for nursing 
care of adult 
patients 
undergoing a PCI, 
developed w/in 
the context of 
nursing practice in 
Australia & New 
Zealand.   
-Developed by 
CV RNs w/a 
systematic 
literature review 
(see Rolley et al., 
[2009] in 








survey of CV RNs  
(see Rolley et al., 
[2010] in 
literature table), a 
modified online 
Delphi Technique, 
& finally a review 
by an 
interdisciplinary 






practices grouped into 
pre-PCI, peri-PCI, & 
post-PCI.   
-Baseline characteristics 
that are risk factors for 
vascular complications.  
-Within post-PCI 
practices ambulation 
post-sheath removal was 
addressed in general and 
with usage of several 
adjunctive therapies (GP 




Review Tool:  




Guideline Review Tool: 
-AGREE II 
-A score of 80% was 
considered high quality 
guidelines r/t to the PICO 
question.   
 




profile, older age, sheath 
size ( > seven Fr AS), & 
females (LOE D).  
RPH: Females, multiple 
punctures within procedure, 
& high & small femoral 
arteries (LOE B).  
Early Ambulation Post-
PCI:  
General: Two to four hours 
bed rest, unless clinical 
conditions indicate 
otherwise(LOE D).  
Adjunctive therapies: 
Bivalirudin: Can decrease 
bed rest from two to four 
hours & start early 
ambulation, (LOE B).  
AGREE II:  
Domain 1: 94% 
Domain 2: 83% 
Domain 3: 82% 
Domain 4: 84% 
Domain 5: 79% 
Domain 6: 83% 
Overall Quality r/t PICO 
question: Good 
Use? Yes, with minor 
modifications 
-AGREE II was 
used, see 
Appendix H.  
- Scope & 
purpose domain is 
94%,  showing 
CPGs are specific 
to nursing care r/t 
a PCI.  
-Despite all 
categories almost 





- Weak evidence 
for early 
ambulation from 
two to four hours 
may be r/t 
heterogenous 







procedures.   
-First nursing 
CPGs r/t PCI  
nursing clinical 
practice & should 





care of patients 
undergoing 
PCIs adds to a 













for CPG & 
actual practice 














































Hoekstra C., van 











early vs. late 
ambulation. Journ
al of Clinical 
Nursing (Wiley-
Blackwell), 18 
























a PCI has 
an impact 


















PCI w/ six Fr AS 










Procedure prior to 
noon. Exclusion: 
CA procedure w/a 
five Fr AS, PSC 




by MD, use of 
anticoagulant 
therapy with an 
INR >/= two,  or 
incapable of  
making decisions, 
inability to  
comprehend 
instructions, or 







(80/100mg). 100 IU 
heparin/kg & PCI >  60 
mins received 2,500 IU. 
RN removed AS w/15 
mins of manual 
hemostatis for 15 mins 
for an ACT < 250 s.  
Ambulation 200 meters 
w/RN post-TIB. D/C 
assessment w/study 
blinded MDs.  
IG: TIB for four hours (n 
= 329) CG: TIB till 
following morning  
(n = 202) 
Variables/ Measures: 
TIB, time of ambulation, 
& PSCs (hematomas, 
bleeding, false 
aneurysms, & AV fistula) 
Instruments: Data: 
Medical/nursing notes  
Bleeding: Manual 
compression or > TIB 
Hematoma:  > five cms 
False Aneurysm & AV 
fistula: Dx by ultrasound 
Statistical Analysis: 
Descriptive & Chi-square 
statistics (x2), Mann–
Whitney U test & t-tests 
Baseline characteristics, 
IG % vs. CG %:  
Women  20.4 vs. 27.7,  
p = 0.051  
-Less women in early in IG.  
-ACT in patients w/ 
complications was between 
78-215 s.  
PSC of IG # vs. CG #:  
Hematoma: 5 vs. 2 
Bleeding: 2 vs. 1 
False aneurysm:  
2 vs. 1 
AV Fistula: 0 vs. 2 
Total PSCs:  
9 (2.7%) vs. 6 (3.0%).  
-Non-inferiority testing 
w/IG as non-inferior w/ 4% 
as a one-sided test.  
- Test for non-inferiority 
shows that the IG’s 
complication rate was not 
increased from the control 





at four vs. ten 
hours post-PCI is 




small number of 
PSCs. 
-The small PSCs 








ten weeks into the 
study from a 
standardized 
dosage of  
10,000 IU IV 
heparin (less than 
10% of 
participants) at 
the beginning of 
study to 5,000 IU 
if PCI  >  60 
mins. 
-Weakness 




LOE, & data from 
one center.  
 -Early 
ambulation at 
four hours post 
PCI may be 
safe, but 
caution should 
be used r/t 
underpowered 
study, low-risk 
patients used & 







































Tongsai, S., & 
Thamlikitkul, V. 
(2012). The safety 
of early versus 
late ambulation in 
the management 



















































conducted.   
-13,592 articles 




Three RCTs & 
two quasi-
experimental 








early (two to four 
hours) or later (six 




duration of bed 
rest > four hours 
in both groups. 
Databases: 
MEDLINE, 








review & meta-analysis 
Variables/Measures: 
TIB & major vascular 
complications (bleeding 
& hematomas)  
Intervention: Early 
ambulation (two to four 
hrs) 
Control: Late ambulation 
(six to ten hrs) 
Instruments: 
Bias: Funnel plot, 
Egger’s test, Begg’s test, 
& trim and fill method 
Heterogeneity: Chi-
square-based statistics 
(x2), measures of 
inconsistency (I 2), & 
between study variances 
(t2) 
Effect size: RR  
Outcomes: Forest plot, 




Bias: Minimal bias on 
funnel plot for hematoma 
events.  
Hematoma events:  
Egger’s test: p = 0.055 
Begg’s test: p = 0.624  
-Trim & fill unchanged for 
hematoma events.   
Bleeding events:  
Egger’s test: p = 0.420 
Begg’s test: p = 0.327 
Heterogeneity: 
Hematoma Events:  
x2 =1.52, p = 0.823, I 2=0, 
& τ2 < 0.0001 
Bleeding Events:  
x2 = 2.46, p = 0.652,  
I2 = 0, & τ2 < 0.0001 
Measures: 
Hematoma events: 
Pooled RR =0.82, 95%  
CI: 0.53, 1.28, p = 0.38 
Trim & Fill Estimate: 
Pooled RR =0.74, 95% 
CI:0.49, 1.12, p = 0.158  
Bleeding Events: 
Pooled RR =1.77,  
95% CI:0.87, 3.59,  
p = 0.117  
-Influence analysis with no 






Tool used, see 
Appendix F. 
- Assuming a 
random effect 






four hrs) vs. late 
ambulation( six- 
ten hrs), in 
causing a vascular 
event post-
femoral PCI.  
-Minor 
publication bias 
did not change 
the author’s 
conclusion (based 




number of studies 







two- four hrs 
vs. six-ten 




















on the results 
of the 
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after a PCI 
mobilized 
at three, 

















 (n = 306) 
Exclusions: 
Excessive 
bleeding of the 
groin puncture 




for hemostasis,   
hematoma before 
arterial sheath 
removal,   
hemostasis taking 
longer > 30 mins, 
non-compliant or   
hypotensive 
patients, & 
patients unable to 
walk.   
 
-Quasi-experimental.  
-Six or seven Fr AS  
w/100 IU/kg of heparin 
given during procedure. 
AS pulled at an ACT of 
170 ms w/10 mg IV 
diazepam & 10mL 1% 
lidocaine subQ around 
the AS. Hemostatis was 
achieved w/a 
FemoStop™ over 30 
mins. Study 
randomization presented 
to staff after hemostasis 
w/a sealed envelope.  
IGs: Three (n = 108) or 
four (n = 100) hrs of bed 
rest  
CG: Six hrs bed rest  
(n = 98) 
Variables/Measures:  
Ambulation time and 
vascular complications    
(hematomas & bleeding 
after AS pull, 
FemoStop™ removal; 
before & after mobility; 
& next morning).  
Instruments: 
Hematoma: >  three cm 
wide at groin site 
Statistical Analysis: 
Descriptive statistics. 
Mann-Whitney U test,  t-
test, Bonferroni 
correction, & analysis of 
variance 
IG (Three vs. Four hrs): 
Baseline Characteristics: 
Female # (%): 20 (18.5) vs. 
22 (22)  
Weight (kg): 86 vs. 83.2  
Bleeding Post-mobility # 
(%): 
15 mins: 1 (0.9) vs. 1 (1) 
60 mins: 1 (0.9) vs. 0 
Hematomas Post-mobility  
(#) %:  
15 mins: 4 (3.7) vs. 5 (5) 
60 min: 5 (4.6) vs. 5 (5)   
Next day: 5 (4.6) vs. 8 (8) 
CG: (Six hrs) 
Baseline Characteristics: 
Female(#) %: 13 (13.26 ) 
Weight (kg): 87.2  
Bleeding Post-mobility: 
none  
Hematoma Post-mobility  # 
(%):  
15 mins: 3 (3) 
60 mins: 3 (3) 
Next day: 7 (7.2) 
Significant Group 
Differences: 
 Four vs. Six hrs  
Post-mobility Bleeding:  
p = 0.047 
Three vs. Six hrs  
Post-mobility Hematoma:  
p = 0.049 





at four vs. six hrs 
and hematomas at 
three vs. six hrs, 
authors claimed 
that no difference 
based on 
hypotheses tested.   
-Although no data 
was collected, 
authors stated no 
RPB, PAS, AV 








one clinical site, 




prior to AS 
removal, & 
methodological 
weakness (lack of 
study timeframe 
& sample number 
rationale).   
-It may be safe 
to ambulate 
patients after 
three hours of 
bed rest after a 
femoral access 
PCI.  
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comparison to a 
similar group in 
NCDR.  
Dates: Inclusion 
was based on the 
# in CS & 
determining an 
equal number in 
the CG.  
CS: May 20, 
2013-December 
31, 2014 (n=249) 









removal & six Fr 
AS used 
 
-Retrospective case study 
-Trained RNs pulled AS 
at bedside. First Two hrs: 
supine & flat. Third hr: 
HOB > 30 degrees or 
turned on sheath side. 
Fourth hr: Free to move 
out of bed. Fifth/Sixth 
hrs: CG  patient 
w/comfort bed position. 
CS: Four hrs TIB  
(n = 152)  
CG Six hrs TIB  
(n = 249) 
Variables/Measures: 
TIB, FAPS, ambulation 
time, & other 
complications in the 
EHR.  
Instruments:  
Data : NCDR & EM. 
NCDR:  RBP; bleeding 
w/in 72 hrs after PCI; 
vascular access site 
hematoma or bleed; Hgb 
decrease by 3g/dl; blood 
transfusion; or 
procedure/surgery. 
EHR: PA, AV fistula, 
RPB, & external bleed 
(bleeding/hematomas).  
Statistical Analysis:  
Two-sample t test, 
Pearson chi-square test, 
logistic regression, OR, 
& adjusted associations 
EHR Baseline 
Characteristics:  
Closure ACT: p  < .001 
Removal ACT: p  <. 001  
GPIIb/IIIa Inhibitors:  
 p = .005 
Mean Age in years (SD):  
71 (12.1) vs. 69.7 (12) 
Male # (%): 112 (74) vs. 
199 (80) 
-Age, gender, & BMI not 
significant. Multi-variable 
modeling for hematomas, 
ACT, & GP IIb/IIIa 
inhibitors was not 
significant.  
EHR CS # (%) vs.  
CG # (%):  
Access Site Bleeding:  
8 (5) vs. 9 (4), p = 0.43 
Hematoma:  
21 (14) vs. 25 (10), 
p = 0.25 
AV Fistula: 
0 vs. 2 (1),  
p = 0.27 
-There were no RPB & 
PSAs in either group.  
NCDR (CS vs.CG): 
Access site bleeding:   
1(1) vs. 2(1), p = 0.87 
Hematoma: 
1 (1) vs. 2 (1), p = 0.87 
Other bleeding:  





CS & CG for 
FAPS 
complications 
w/in the NCDR 
or institution 
EHR between 
four vs. six hours 
of bed rest post- 
PCI.  
-NCDR bleeding 
rates w/in this 
study comparable 







ACT & use of GP 
IIb/IIIa inhibitors) 
data that was not 
statistically 






beyond study (r/t 
underpowered 
study), & low 
LOE.  




four hours vs. 
six hours of 
bed rest after a 
femoral PCI 
using a seven 












quality of care 
& overall 
outcomes in a 
PCI.  
-First study to 
use a larger 
catheter than 
five-six Fr AS. 
-Would add to 
nursing 
literature 
redesigned as a 










Note. & = and; + = plus; % = percent;  < = less than;  >  =  greater than;  # =  number of;  / =  per; ACCF = American College of 
Cardiology Foundation; ACS = acute coronary syndrome; ACT = activated clotting time; AGREE II = appraisal of guidelines for 
research & evaluation; AHA = American Heart Association; aPTT =  activated partial thrombin time; AS = arterial sheath; AV= 
arteriovenous; CA = coronary angioplasty; BMI = body mass index; CAD = coronary artery disease; CC = cardiac catherization or 
coronary angiogram; CG = control group; CHF = congestive heart failure; CI = confidence interval; cm = centimeter; COPD = chronic 
obstructive pulmonary disease; CPGs = clinical practice guidelines; CPS = clinical practice standards; CS = case study; CV = 
cardiovascular; DAPT = dual antiplatelet therapy; D/C = discharge; dx = diagnosis; EA = early ambulation; EHR= electronic health 
record; FAPS = femoral arterial puncture site complications; Fr =French (arterial sheath); f/u = follow-up; G1= Group 1; G2 = Group 
2; G3 = Group 3; GP IIb/IIa = glycoprotein IIb/IIIa inhibitors; H = heterogeneity; HDV = healthcare delivery values; Hgb = 
hemoglobin; hrs = hours;  ; HOB = head of bed; hx = history; IG = intervention group; INR = international normalized ratio; IU =  
international units; IV = intravenous; kg = kilograms; LA = late ambulation; LOE = level of evidence; LMWH = low molecular 
weight heparin; MD = medical doctor; mg = milligram; min = minutes; mL = milliliters; ms = milliseconds; NCDR = National 
Cardiovascular Data Registry; NSTEMI = non-ST segment elevation myocardial infarction; OR = odds ratio; PAS = 
pseudoaneurysms; PAD = peripheral arterial disease; PCI = percutaneous cardiac intervention;  PCS = puncture site complications; pts 
= patients; RCTs = randomized control trials; RF = risk factor; RNs = registered nurses; RPH = retroperitoneal hematoma; r/t = related 
to; s = seconds; SCAI = Society for Cardiovascular Angiography and Interventions; SD = standard deviation; SDD = same-day 
discharge; STEMI = ST segment elevation myocardial infarction; subQ = subcutaneous; TIB = time in bed; VCD = vascular closure 









DiCenso, Guyatt and Ciliska’s (2005) Meta-Analysis Tool for Kim et al. (2013)  
Questions to ask: 
1. Are the results of the individual studies included similar across studies? 
a. Yes, Figure 3 shows the results in odds ratio (OR) within the Mantel-Haenszel. 
One outlier in the hematoma section (four versus six hours), and two within the 
hemorrhage section. 
2. Are the differences between studies truly differences or did the occur by chance? 
a. Examine the extent to which the CIs of the individual studies overlap. The greater 
the overlap, the more comfortable one can be in combining results.  
i. There is overlap, more so in the hematoma vs. hemorrhage outcomes. For 
hematoma, the confidence interval (CI) is 0.68 to 1.17, while the 
hemorrhage data has a CI from 0.77 to 1.7. The results for the hematoma 
data are more precise.  
b. Examine whether the authors conducted statistical analysis of heterogeneity; the 
degree of difference among study findings. The more significant the test (often 
chi-square), (p-value < 0.50), the less likely the observed differences were due to 
chance alone.  
i. Both use the chi-square statistic only. For the hematoma data, p = 0.8003, 
and for the hemorrhage data, the p = 0.7632. The test is set at  p < 0.50, 
which is standard. Since there is no significant heterogeneity, the authors 
paired this together. However, there is no I2 statistic to assess the index of 







considering 0% and indicates no heterogeneity. It would be nice for it to 
be calculated for this study, but it was not. 
3. Does the review address a sensible clinical question? 
a. Yes, but no clinical question is asked, statements are made in the object in the 
intro and methods section. 
4. Does the review describe population, intervention/treatment, outcome(s) considered? 
a. Population: post-femoral PCI (not implied in the beginning, but radial artery 
access studies were excluded in the limitation section of the article). 
b. Intervention: early ambulation. However, early ambulation was not defined till 
after the search was complete. Early ambulation ranged from one-and-a half to six 
hours.  
c. Outcome: no difference between early and late ambulation in regards to bleeding 
and hematomas.  
5. Is the review question clearly stated? 
a. No. A review question is not clearly stated.  
Literature Review 
6. Were comprehensive search methods used to locate studies? 
a. Yes, this is explained in the methods section and in Figure 1, or the flow diagram 
analysis. The characteristics of the studies were defined in Table 1.  
7. Was a thorough search of appropriate databases done? 
a. Yes, this is explained in the methods section and in Figure 1, or the flow diagram 








8. Were other potentially important databases explored? 
a. Only the databases listed were explored. No search of the reference lists or gray 
literature.  
9. Were the search methods clearly described? 
a. Yes, much more clear than other sections within the paper. 
10. Were conclusions drawn about the possible impact of publication bias? 
a. Publication bias was addressed and the conclusion drawn was that there was no 
publication bias using Macaskill’s test, regression analysis and a Funnel plot. 
Macaskill’s test has a lower power than the alternative tests purposed. With low 
power and likely a p-value of 0.05, there is a chance that a Type II error could be 
made (not rejecting the null hypothesis in which there is no publication bias, when 
in fact there could be publication bias).   
11. Were the overall findings assessed for their robustness in terms of the selective 
inclusion or exclusion of doubtful or biased studies? 
a. It is unclear as three independent reviewers looked at the studies, but did not 
include anything in the review of why articles were included or excluded based on 
bias.  
Study Selection 
12. Were inclusion and exclusion criteria clearly described and fairly applied? 










Critical Appraisal of the Studies 
13. Was study quality assessed by blinded or independent raters? 
a. Yes, the study was assessed by three independent raters for all articles used in this 
study.  
14. Was the validity of included studies assessed? 
a. Validity was not overtly addressed. Figure 1 addresses the process, and Table 1 
and Table 2 state the characteristics of the studies. There is not a table addressing 
the statistical validity of the studies. There are strict limiting conditions though 
and all studies were reviewed by three independent reviewers. 
15. Was the validity of studies assessed appropriately? 
a. It is implied, but not overtly stated.  
16. Are the validity criteria reported? 
a. See Table 1, which tells why each one was included but does not address the 
individual statistical results. No statistical analysis was a limiting factor per 
authors.  
17. Were the primary studies of high methodological quality?  
a. Two studies were quasi-experimental, three were prospective randomized control 
trials (RCTs), and 10 were RCTs.  
Similarity of Groups, Treatments and Outcomes 
18. Were reasons given for any differences between individual studies explored? 
a. Yes, differences between studies was explored extensively. In Table 2, the 
characteristics of different studies were discussed. In the discussion section there 







studies had early ambulation at two-and-a-half to six hours, while studies 
conducted after 2001, early ambulation ranged from one-and-a-half to four hours. 
The authors acknowledged that this was a shorter time period and that the longer 
period in earlier studies may have been due to lack of knowledge for optimal 
ambulation time, as a standard had not been set.  
b. Other differences addressed were the location of the studies (more studies outside 
of North America were published later perhaps due to increased numbers of 
deaths from the rising rates of cardiovascular disease), differences in the labeling 
and measurement of hematomas and bleeding (only 10 studies mentioned the 
differences in measurement), usage of certain drugs (high levels of antiplatelet 
agents such as in the study by Höglund, Stenestrand, Tödt, & Johansson [2011]), 
and very short ambulation times (Best et al., 2010).  
c. A reasonable conclusion was drawn that one should “carefully consider the 
difference in study subjects the sizes of the insertion tubes used, the usage of 
antiplatelet and anticoagulation agents, and the methods of hemostasis at the 
puncture site to avoid intercepting the study results too broadly.” (Kim et al., 
2013, p. 435). In the conclusion, Kim et al. (2013) reasonably stated to consider 
the above factors, as well as the gender, and sizes of tubes placed in order to 
accurately apply the results.  
19. Are treatments similar enough to combine? 
a. It does not appear so based on the differences listed in question 18 despite being 
the same procedure. The test of heterogeneity at,  p = .8003,  and dp = .7632 do 








b. The authors thought they were estimating the same effect and used the fixed 
effect model. Since a fixed-effect model was used and this does not reflect the 
true population, the authors suggest proceeding with caution when broadly 
applying results in clinical practice.  
20. Are the outcome measures similar between studies? 
a. All the studies are quite similar, as indicated in Figure 3.  
21. Do the included studies seem to indicate similar effects? 
a. Yes, it indicates that early ambulation does not lead to increased bleeding and 
hematomas at the puncture site.  
22. If not, was the heterogeneity of effects assessed and discussed? 
a. Non-applicable.  
23. How precise were the results? 
a. Since this is a fixed effect model with no heterogeneity, the results are precise, but 
the data about hematoma results are more precise than the data regarding the data 
about bleeding results.  
Data Synthesis 
24. Were the findings from individual studies combined appropriately?  
a. Per the authors, they believed they were measuring the same thing, but did report 
a degree of error in the measurements of hematomas differently and did not define 
the degree of bleeding at the puncture site.  
25. Are the methods to combine studies reported? 







26. Was the range of likely effect sizes presented? 
a. Yes, in Figure 3.  
27. How precise were the results? 
a. Using the fixed-model, the results are precise. The results are more precise for 
hematoma results vs. the bleeding results.  
28. Were null findings interpreted carefully? 
a. Yes, the null findings were discussed and interpreted carefully. The authors noted 
that a fixed effects model was used and caution should be taken when assessing 
results and applying them. The authors discuss that in theory, early ambulation 
should work, but caution should be taken considering other factors.  
29. Are review methods clearly reported? 
a. For the most part yes, Table 2 could be revised to better display the results.  
30. Application of results to Patient Care 
a. Is a practice change warranted? Were all the important outcomes considered?  
i. Yes, this is a high level of evidence study with a rigorous search method 
and no statistical difference, despite the low count of studies. The authors 
are reasonable when suggesting caution when applying the results. 
b. Are the benefits worth the costs and potential risks?  
i. Yes, early ambulation can benefit the patient if considering stated risk 
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DiCenso, Guyatt, and Ciliska’s (2005) Meta-Analysis Tool for Mohammady, Atoof, Sari, 
and Zolfaghari (2013) 
Questions to ask 
1. Are the results of the individual studies included similar across studies? 
a. Five studies were included with similarities of population, test, and outcomes. 
However, limitations included differences in bed rest times, follow-up time (two-
48 hours) after practice, and other demographics were not recorded to evaluate 
(gender, age, and type of medication used). 
2. Are the differences between studies truly differences or did the occur by chance? 
a. Examine the extent to which the confidence intervals of the individual studies 
overlap. The greater the overlap, the more comfortable one can be in combining 
results.  
i. All of the outcomes overlapped except for the hematoma outcomes for 
four-six hours vs. eight hours with the difference in in Figure 3. However, 
there is a significant difference is in favor of the four-six hours as the 
outcomes are to the left of the line. This is irrelevant as it is not the subject 
that is being compared.  
b. Examine whether the authors conducted statistical analysis of heterogeneity; the 
degree of difference among study findings. The more significant the test, often 








i. Assessing the Forest plots in  Figure 3,4,5, and 6, the significant level is 
set at, p  < 0.10, in order to compensate for smaller sizes. 
3. Does the review address a sensible clinical question? 
a. The review answers a clinical statement, not a question. The clinical statement 
addresses the difference in bed rest durations and how this can increase or 
decrease vascular complications, and additionally how it affects back pain and 
urinary problems.  
4. Does the review describe population, intervention/treatment, outcome(s) considered? 
a. Population: not clearly defined, but PCI participants are listed throughout the 
study as included. In Appendix 1, the central search strategy used the term 
transfemoral as opposed to femoral.  
b. Intervention/treatment: bed rest timeframes.  
c. Outcomes: hematoma, risk of bleeding, risk of pseudoaneurysm, and arterial 
venous (AV) fistula.   
5. Is the review question clearly stated? 
a. There is no question, but a section with aims of assessing the outcomes.  
Literature Review 
6. Were comprehensive search methods used to locate studies? 
a. Yes, the databases were listed, as well as the gray literature. However, one had to 
search for this within the article as the comprehensive search methods were not 









7. Was a thorough search of appropriate databases done? 
a. Yes, a thorough search of appropriate databases was listed in Appendix 1 with the 
mesh terms and general key terms used.  
8. Were other potentially important databases explored? 
a. The authors stated that the gray literature was searched, but the PRISMA flow 
diagram in Figure 1 does not state the identify or where the other five studies 
reviewed came from.  
9. Were the search methods clearly described? 
a. Yes, it was outlined in the Figure 1 and throughout the article.  
10. Were conclusions drawn about the possible impact of publication bias? 
a. Yes, the authors used the Cochrane Collaboration Tool for assessing the risk for 
bias in included studies. It was ruled that the risk for bias was unclear for 80% of 
the studies. There are no specific tools used to assess publication bias, but authors 
did state there was a low risk for selective reporting or reporting bias in all five 
studies.   
11. Were the overall findings assessed for their robustness in terms of the selective inclusion 
or exclusion of doubtful or biased studies? 
a. Yes, the studies were assessed for selective inclusion and exclusion of doubtful or 
biased studies.  
Study Selection 
12. Were inclusion and exclusion criteria clearly described and fairly applied? 
a. Inclusion was easier to identify than exclusion within the study. One has to look 







Critical Appraisal of the Studies 
13. Was study quality assessed by blinded or independent raters? 
a. Yes, two reviewers assessed the quality of each study, disagreements were 
resolved by discussion, and data was extracted according to a structured format. 
The Cochrane Collaboration Risk of Bias Assessment Tool was used to appraise 
the acuity of the included studies.  
14. Was the validity of included studies assessed? 
a. No, the validity of the included studies was not well assessed. There is no 
statistical analysis of the validity of the studies and the methodology of the studies 
vary greatly.  
15. Was the validity of studies assessed appropriately? 
a. Likely not. A fixed effect method model was used, making one unable to apply 
the results to the general population. To assess bias, the Cochrane Collaboration 
Risk of Bias Assessment tool was used and reported bias for 80% of the studies.    
16. Are the validity criteria reported? 
a. There was an independent review by two reviewers to assess the quality of the 
studies and disagreements resolved by discussion.  
17. Were the primary studies of high methodological quality?  
a. Yes, the studies were only randomized control trials (RCTs) and quasi-RCTs were 










Similarity of Groups, Treatments and Outcomes 
18. Were reasons given for any differences between individual studies explored? 
a. Yes, it was discussed that hemostatis methods of the studies might make a 
difference in the results (FemoStop™, manual pressure, but no vascular 
compression devices).  
19. Are treatments similar enough to combine? 
a. Yes, tests of heterogeneity were used and did not show any differences as authors 
were looking at the same population.  However, it was acknowledged that 
differences such as adjective therapies, gender, and age were missing and might 
make a difference in the effect of the study.  
20. Are the outcome measures similar between studies? 
a. Yes, all studies had a control and experimental group.  
21. Do the included studies seem to indicate similar effects? 
a. Yes, the difference in bed rest is not statistically significantly. Some studies did 
not look the same effects, make it difficult to compare outcomes such as AV 
fistulas and pseudoaneurysms.  
22. If not, was the heterogeneity of effects assessed and discussed? 
a. Despite no statistical differences in heterogeneity of effects, authors discussed in 
the discussion, limitations, and conclusion that there are differences in outcomes 
studied, definitions of these outcomes, wide range of time periods, follow-up time 
varying, assessing the difference in duration of bed rest by gender age, and types 








23. How precise were the results? 
a. Hematoma and bleeding.   
i. Two-four vs. six was more precise than three vs. 10.  
b. For pseudoaneurysms results, there was only one per group and there was a wide-
variations, thus not as precise as the out types of vascular complications   
i. For AV fistula, there were no events for the two-four vs. six-hour group 
and thus could not be calculated.  
Data Synthesis 
24. Were the findings from individual studies combined appropriately?  
a. Yes, the appropriately combined findings are listed in Table 1 (the general 
characteristics of the included studies). In other words, the highest level of 
evidence was chosen, but there were still some differences noted.  
25. Are the methods to combine studies reported? 
a. Yes, the Mantel-Haenszel fixed effect model was used with effect size of each 
study in Figures 3,4,5, and 6.  
26. Was the range of likely effect sizes presented? 
a. Yes, but the range of likely effect sizes was scattered throughout Figures 3, 4,5, 
and 6.  There was no individual table for the effect size of each study, only a 
discussion of general characteristics of included studies in Table 1.  
27. How precise were the results? 
a. The Forest plots in Figures 3,4,5, and 6 show overlap for all studies. The most 
precise results were comparing two-four hours versus six hours in Figure 2, which 







28. Were null findings interpreted carefully? 
a.  The null findings were interpreted carefully, but there could be further discuss 
regarding all the variable addressed and why hematomas had more precise results, 
while bleeding, pseudoaneurysms, and AV fistulas did not.  
29. Are review methods clearly reported? 
a. Yes, review methods are clearly reported within the methods section.  
Application of results to Patient Care 
30. Is a practice change warranted? Were all the important outcomes considered? Are the 
benefits worth the costs and potential risks?  
a. Yes, I think a practice change would be warranted as it does address the many 
vascular outcomes that can happen during a PCI. Despite the Forest plots in 
Figure 5 and 6 favoring later ambulation, it should be noted that the 
pseudoaneurysm and AV fistulas events are very small throughout all the studies 
reviewed. I think the practice change would be safe, but the cost is unclear. The 
practice change would benefit from being part of a larger RCT that analyzes 
vascular outcomes in relation to risk factors and overall cost saving.   
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Appendix F  
DiCenso, Guyatt, and Ciliska’s (2005) Meta-Analysis Tool for Tongsai & Thamlikkul 
(2012) 
Questions to ask: 
1. Are the results of the individual studies included similar across studies? 
a. The effect size is listed on Table 2. No results from the individual studies were 
statistically significant for a hematoma or a bleeding event, but the risk ratio (RR) 
or the effect size varied by study.  
2. Are the differences between studies truly differences or did the occur by chance? 
a. Examine the extent to which the CIs of the individual studies overlap. The greater 
the overlap, the more comfortable one can be in combining results.  
i. Hematoma: all results overlap for the most part on the Forest plot in 
Figure 3, but Augustin et al. (2010), reports a larger confidence interval 
(CI), but with a sample size of two for that event, and thus this smaller 
sample size can lead to a larger CI and less precision (0.06-16.14). 
ii. Bleeding events: wider ranges of CIs, but they do overlap and lead to a 
narrower pooled CI.  
b. Examine whether the authors conducted statistical analysis of heterogeneity 
(variation in study outcomes between the studies) the degree of difference among 
study findings. The more significant the test (often chi-square), (<.05), the less 
likely the observed differences were due to chance alone.  
i. Hematoma 







a. Hematoma events were not significant. Values of  p < 0.10 
or I2 > 50%, were needed per the study for the test to be 
considered statistically significant. The p-value was not 
significant, although the p-value can have a lower power 
when the number of test is small. This was considered by 
the authors and a higher significant level was taken here or 
p < .10 and  I 2 = 0. These results show no changes in 
heterogeneity, or in other words it shows homogeneity (this 
is a more comprehensive test that does not need the number 
of studies and measures the percent of variation across 
studies). Finally, the tau squared which is less than zero, 
shows the observed variance is less than expected based on 
the within study variance.  
b. A random effects model was used first, perhaps due to the 
fact that the authors assumed that the effect would not be 
the same in all the studies (based on Table 2). This was 
seen in Figure 3 & 4. Using the random effects model is 
less powerful because p-values are larger and the CIs are 
wider. However, the studies are a sample from a 
population, and studies with varying effects may be truly 
representative of the overall population. Fixed effect 
models on the other hand assumes the effect is the same in 







studies, it is more powerful and easier, no assumptions 
though about representation.  
2. Results were viewed from both random and fixed models, but first 
a random effect model. The authors justified this by stating the 
reasoning was for using the random effects model was due to the 
author’s perception of the studies and their overall goals. Reasons 
included: different independent studies from several difference 
countries, and inferences based on random effects model can be 
generalized beyond the studies included in the meta-analysis. Thus, 
the studies can be pooled together to generate a single summary 
result.  
ii. Bleeding events  
1. Bleeding events: x2 = 2.46, p = 0.652,  I 2 = 0, & τ2 = < 0.0001 
a. Bleeding events were not significant. The statistical 
parameters for significance were p < 0.10 or I 2 >  50%. The 
p-value was not significant (although the results can have a 
lower power when the number of test is small, but this was 
considered and higher significant level was taken here or  
p  <  .10,  the I 2 = 0 and shows no heterogeneity. Finally, 
the tau squared which is less than zero, shows the observed 
variance is less than expected based on the within study 
variance. Thus, the studies can be pooled together to 







3. Does the review address a sensible clinical question? 
a. No clinical question is asked, but a clinical statement is posed in the abstract, 
introduction, and conclusion. Yes, it addressed a clinical statement that cannot be 
answered despite the supportive literature in regards to implications for patient 
outcomes (pain, early ambulation, and comfort) and financial implications 
(decrease length of stay and early discharge). The clinical question also asks if 
any more primary studies need to be conducted.   
4. Does the review describe population, intervention/treatment, outcome(s) considered? 
a. Population: post-femoral access PCIs was not defined as easily, but is stated twice 
that femoral procedures were part of the population studies, once in the 
introduction and once in the discussion section. It is not included nor excluded in 
either the inclusion and exclusion for the literature search. It is stated later on that 
the population was focused on PCI through the femoral approach.   
b. Intervention: clearly defined. Early ambulation at two-four hours and late 
ambulation at six-ten hours. This is stated in the methods section, inclusion 
section, and throughout the article. 
c. Outcomes: no difference stated and the practice change should happen without 
any more primary studies. 
5. Is the review question clearly stated? 
a. Review question not clearly defined, but a statement of why the meta-analysis is 
being employed is stated as such, “Therefore, we performed a meta-analysis of 







undergoing PCI and if it should be implemented without performing more 
primary clinical studies” (Tongsai, & Thamlikitkul, 2012, p. 1085).  
Literature Review 
6. Were comprehensive search methods used to locate studies? 
a. Yes, date, database location, key terms used, but the only thing was no limit on 
timeframe, a reason was not given for this, but it ended up being from 2001 to 
2011.  It would have been helpful to include an appendix for clarity.  
7. Was a thorough search of appropriate databases done? 
a. Yes, large databases such as PubMed, Web of Science, Cochrane Library, 
Embase, gray literature, and references lists were assessed for potential articles.   
8. Were other potentially important databases explored? 
a. Yes, the gray literature was also searched, along with each reference hand 
searched.  
9. Were the search methods clearly described? 
a. Yes, a literature search with a flow diagram was provided. Inclusion and 
exclusion were clearly laid out.  
10. Were conclusions drawn about the possible impact of publication bias? 
a. Yes, publication bias was addressed in a rigorous fashion. The funnel plot for 
hematoma, Figure 2A, showed “minimal evidence of publication bias.” Both the 
tests Egger’s & Begg’s test did not show there was no publication bias, but that 
there was not significant publication bias present. Adjusting for publication bias 
with the trim and fill method and did not change the pooled RR of bleeding. The 







0.74 (95% CI: 0.49, 1.12, p = 0.158). 
b. Even placing studies in a sensitivity analysis in Figure 5, did not have any large 
effects for hematoma. Furthermore, the authors said including the gray literature 
may have reduced potential publication bias and exclusion could have led to a 
further asymmetrical funnel plot.  
c. Authors acknowledged that adjustment for publication bias did not change the 
conclusions of the study and stated that publication bias was unlikely to have 
effect on the conclusions of the analysis.  
d. Publication bias that can occur when studies with positive results (or significant 
results) are more likely to be published than studies with negative or inclusive 
results. Researchers may be reluctant to write up a paper for publication that has 
non-significant results. Test for bias are usually underpowered and even non-
significant results can actually have publication bias. Publication bias can be 
affected by small studies as well. 
e. Trim and fill method can be used to see what the effect would be like if no 
publication bias was present.  
11. Were the overall findings assessed for their robustness in terms of the selective inclusion or 
exclusion of doubtful or biased studies? 
a. Yes, the findings were deemed “robust” (p. 1085), by Tongsai and Thamlikitkul 
(2012),  due to their adjustments for publication bias after using the trim and fill 
method and excluding publication bias. The authors deemed that only one study 
minimally changed results for bleeding. There was no exclusion, but 








12. Were inclusion and exclusion criteria clearly described and fairly applied? 
a. Yes. Inclusion and exclusion are stated in the literature search section and in the 
flow diagram in Figure 1.  
Critical Appraisal of the Studies 
13. Was study quality assessed by blinded or independent raters? 
a. No.  
14. Was the validity of included studies assessed? 
a. Yes, it was stated in the methods and result sections. It was summarized in the 
flow diagram in Figure 1 and Table 2. The validity of the studies mainly revolves 
around the statistical validity.  
15. Was the validity of studies assessed appropriately?  
a. Yes and no. Authors names who reviewed the data not given, how they decided 
upon why the five articles were used. However, the inclusion criteria were strict 
and may have only been able to include the timeframe criteria for the control and 
intervention groups.  
16. Are the validity criteria reported? 
a. Yes, in the flow diagram and within the results section. 
17. Were the primary studies of high methodological quality?  
a. Yes, three were randomized control trials and two were quasi-experimental. 









Similarity of Groups, Treatments and Outcomes 
18. Were reasons given for any differences between individual studies explored? 
a. The reason was mentioned, but not explored in-depth.  
19. Are treatments similar enough to combine? 
a. Yes, treatments were similar to combine by assessing the CIs and the 
heterogeneity. Despite the differences in measurement which was stated, there 
was over overlap and statistical measurement for similarities. 
20. Are the outcome measures similar between studies? 
a. The RR was for the most part similar, as seen in Table 2.   
21. Do the included studies seem to indicate similar effects? 
a. Yes, almost all studies indicated similar effects, not difference in early vs. late 
ambulation.  
22. If not, was the heterogeneity of effects assessed and discussed? 
a. Yes, the heterogeneity was discussed and there was no difference and even a 
higher p-value was used to account for the small number of studies.  
23. How precise were the results? 
a. The Forest plots in Figure 4 show overlap and for all the studies. The precision for 
hematoma events was much less for hematoma events vs. bleeding events in 
Figure 3 and 4. However, with little heterogeneity within the random effects 











24. Were the findings from individual studies combined appropriately?  
a. Yes, an effect size was calculated in Table 2 and the endpoints and similar control 
vs. intervention group results were part of the inclusion criteria.  
 
25. Are the methods to combine studies reported? 
a. Yes, effect size was reported in Table 2 as a RR.  
26. Was the range of likely effect sizes presented? 
a. Yes, the likely effect size can be seen in Table 2 and in the Forest plots in Figure 
3 and Figure 4.  
27. How precise were the results? 
a. The Forest plots in Figure 4 show overlap and for all the studies. The precision for 
hematoma events was much less for hematoma events vs. bleeding events in 
Figure 3 and 4. However, with little heterogeneity within the random effects 
model, the results for bleeding events could be considered more precise.   
28. Were null findings interpreted carefully? 
a. Yes, the null findings were helpful in this situation, as the intervention should not 
cause any bleeding.  
29. Are review methods clearly reported? 










Application of results to Patient Care 
30. Is a practice change warranted? Were all the important outcomes considered? Are the 
benefits worth the costs and potential risks?  
a. Yes, I think a practice change would be warranted, especially since this is a high 
level of evidence. I think that looking at all vascular changes would be further 
warranted from a RCT from an inter-disciplinary perspective.  
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BROUWERS ET AL.’S (2010) Agree II Tool for Levine et al. (2011) 
PICO Question: 
(P) In adult patients undergoing PCI with a femoral access, (I) does early ambulation at or less 
than four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O) 
have any impact on a patient’s risk of vascular complications?   
Grading Criteria: 
High quality guidelines are 80% or greater in relation to the PICO question. Scoring 1 (strongly 
disagree) to 7 (strongly agree).  
Domain 1: Scope & Purpose 
1. The overall objective(s) of the guideline is (are) specifically described. (5)  
a. This guideline is used to help physicians/advanced care providers select the best 
strategies for managing care of patients undergoing percutaneous cardiac 
interventions (PCIs) patients, creating clinical decision support tools, performance 
measures, quality improvement, and appropriate use criteria. Although this guideline 
is thorough in specifically describing medical interventions, outcomes, and 
pharmacology for the procedure and adjunctive therapies, it does not describe in 
detail the cares of patient after the procedure in regards to time in bed (TIB), and 
early ambulation, who relate to this research question. It was given a score of (5) 
because it does address important elements to the success of early ambulation 









2. The health question(s) covered by the guideline is (are) specifically described. (3)  
a. This is an extremely broad clinical guideline that looks at the history, evolution, further 
research, and current practices with the best evidence for PCIs. Although it addresses 
many important parts of the procedure in detail, especially regarding the usage of 
adjunctive therapies to prevent restenosis, it does not address the PICO question or 
provide any guidance to writing a facility policy on early ambulation post-femoral PCI. It 
was given a score of (3), because it does address important elements to the success of 
early ambulation (populations, comorbidities, and vascular closure devices). 
3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically 
described. (7)  
a. The population is adult patients undergoing percutaneous coronary intervention within 
the United States.  Co-morbidities such as diabetes mellitus, chronic kidney disease, and 
specific populations are addressed (women, elderly, diabetics, and cardiac allografts) are 
addressed. The authors even considered that literature not published in North America, 
may not reflect the drugs, different practice patterns, and patient populations and 
relevance to target population into account during review.  
 
Item: 1 2 3 Total 
Appraiser 
#1 
5 3 7 15 
 








Doman 2:Stakeholder Involvement 
4. The guideline development group includes individuals from all relevant professional groups. 
(3)  
a. The guideline development only included physicians, however these physicians are 
considered experts in their fields of interventional cardiology, generally cardiology, 
critical care cardiology, cardiothoracic surgery, clinical trials, and health service research. 
The professional groups of the American College of Cardiology Foundations, Society for 
Cardiovascular Angiography and Interventions, and the American Heart Association had 
physician representatives on the writing committee. This was given a score of (3) because 
it did not include all stakeholders including patients, nurses, pharmacist, nursing aides, 
family members, EKG technicians, echo technicians, & catherization lab technicians, all 
which play a part in the PCI process.  
5. The views and preferences of the target population (patients, public, etc.) have been sought.       
(1) 
a. The views of the public in the guidelines are not easy to find. The only mention of this 
topic is in regards to “patient preference” to have a PCI or a coronary artery bypass graft 
for significant coronary artery stenosis and unacceptable angina that cannot be given 
guideline-directed medical therapy/medical therapy. It does not assess patient preference 
in any other topics throughout the guideline.  
6. The target users of the guideline are clearly defined. (5) 
a. Several times healthcare providers or healthcare workers are used, but mainly the term 
physician is used. It is clear that the guidelines are for a healthcare provider, but does not 








Item: 4 5 6 Total 
Appraiser #1 2 1 5 8 
 
Domain #2 Score: 27% 
Domain 3: Rigor of Development 
7. Systematic methods were used to search for evidence. (4) 
a. A search of the literature with listed terms was conducted from November 2010- 
August 2011. Inclusion criteria included studies, reviews, and other evidence conducted 
on human subject and published in the English language. Key terms used were noted 
within the methodology section. There was discussion on exclusion of articles from other 
countries that did not pertain to the North American population, but this exclusion was 
not laid out in detail. There were no key terms relating to early ambulation, time in bed, 
or bed rest. Databases were not listed, but authors did state references could all articles 
used could be found for easy use in PubMed. There was not an appendix with search 
strategies. There would not be enough information to replicate a search.  
8. The criteria for selecting the evidence are clearly described. (2) 
a. The population is well-defined. Inclusion and exclusion are poorly defined. There are 
879 references so it hard to tell if any relevant literature was excluded. 
9. The strengths and limitations of the body of evidence are clearly described. (6) 
a. The Class of Recommendations and Level of Evidence or CC/AHA Clinical Practice 
Guideline Recommendation Classification System was used to evaluate all guidelines in 







recommendations to early ambulation or decreased bed rest, only independent variables 
related to early ambulation were graded (populations, comorbidities, & vascular 
compression devices).  
10. The methods for formulating the recommendations are clearly described. (6) 
a. As listed above, the Class of Recommendations and Level of Evidence or CC/AHA 
Clinical Practice Guideline Recommendation Classification System was used to score the 
evidence by expert physicians in the field as well as members from professional 
organizations listed above into a task force. The task force and peer reviewers also listed 
relationships within the industry (as well as how they pertain to this guideline) and tried 
to avoid conflicts of interest were listed in Appendix 1 and 2. All guidelines were voted 
on during meetings or conference calls, and had to have the confidence vote by the 
writing committee and updates as changes occurred. The guidelines were also subject to a 
pilot project and were made more accessible, shorter, and easy to use based on these 
recommendations. This question was given a score of (6) because it did not grade any 
specific recommendations to early ambulation or decreased bed rest, only independent 
variables related to early ambulation were graded (populations, comorbidities, & vascular 
compression devices).  
11. The health benefits, side effects, and risks have been considered in formulating the 
recommendations. (6) 
a. The guidelines assess the health benefits, side effects, and risk in extensively and with 
proper guidance with the Class of Recommendations and Level of Evidence or CC/AHA 
Clinical Practice Guideline Recommendation Classification System. This question was 







ambulation or decreased bed rest, only independent variables related to early ambulation 
were graded (populations, comorbidities, and vascular compression devices). 
12. There is an explicit link between the recommendations and the supporting evidence. (4) 
a. The guidelines are based on many studies, but are organized by the procedure 
timeframe. Post-procedural care items such as bed rest and early ambulation were not 
easy to find. 
13. The guideline has been externally reviewed by experts prior to its publication. (5) 
a. The guideline had been reviewed by expert peer reviewers listed in Appendix 2, but 
their credentials were not listed. Authors also stated that a pilot release of the guidelines 
was assessed and modifications were made prior the final version. Guidelines were 
reviewed by physicians only.  
14. A procedure for updating the guideline is provided. (3) 
a. It is acknowledged that the guideline will need future updates, but a procedure is not 
stated, nor a timeframe is given.  
Item: 7 8 9 10 11 12 13 14 Total 
Appraiser 
#1 
4 2 6 6 6 4 5 3 36 
 
Domain #3 Score: 58% 
Domain 4: Clarity of Presentation 
15. The recommendations are specific and unambiguous. (2) 
a. The authors state that clinical judgement should be used when making decisions 







any specific recommendations to early ambulation or decreased bed rest, only 
independent variables related to early ambulation were graded (populations, 
comorbidities, and vascular compression devices).  
16. The different options for management of the condition or health issue are clearly presented. 
(3) 
a. Different options and considerations for comorbidities and special populations were 
taken. This question was given a score of (3) because it did not grade any specific 
recommendations to early ambulation or decreased bed rest, only independent variables 
related to early ambulation were graded (populations, comorbidities, and vascular 
compression devices). 
17. Key recommendations are easily identifiable. (3)  
a. The recommendations for bed rest and early ambulation can only be surmised from 
only independent variables related to early ambulation (populations, comorbidities, and 
vascular compression devices). There are no specific recommendations within the post-
procedural care section regarding ambulation, just on adjunctive therapies, cardiac rehab, 
exercise testing, and return to work recommendations.  
Item: 15 16 17 Total 
Appraiser #1 2 3 3 8 
 
 









Domain 5: Applicability 
18. The guideline describes facilitators and barriers to its application. (3) 
a. Barriers and facilitators are described throughout the guidelines, but it is not all in one 
place, nor does it address the barriers and facilitators or early ambulation. 
19. The guideline provides advice and/or tools on how the recommendations can be put into 
practice. (3) 
a. Guidelines address how advice/tools can be put into medical practice, but not nursing 
practice. There are few algorithms and checklists that can be utilized in daily care.  
20. The potential resource implications of applying the recommendations have been considered. 
(5) 
a. The authors discuss the procedure and acknowledge realistic obstacles including cost. 
This question was given a score of (5) because it did not grade any specific 
recommendations to early ambulation or decreased bed rest, only independent variables 
related to early ambulation were graded (populations, comorbidities, and vascular 
compression devices) . 
21. The guideline presents monitoring and/or auditing criteria. (4)  
a. Brief paragraphs regarding angiographic and procedural monitoring and clinical 
success are addressed. This question was given a score of (4) because it did not grade any 
specific recommendations to early ambulation or decreased bed rest, only independent 
variables related to early ambulation were graded (populations, comorbidities, and 









Item: 18 19 20 21 Total 
Appraiser #1 3 3 5 4 15 
 
Domain #5 Score: 46%  
Domain 6. Editorial Independence 
22. The views of the funding body have not influenced the content of the guideline. (7)  
a. The task force banned anyone from writing or voting on items that they had 
relationships with the industry or conflicts of inters with. This was given a (7) due to 
measures taken to ensure ethical clinical guidelines.  
23. Competing interests of guideline development group members have been recorded and 
addressed. (7) 
a. Appendix 1 and 2  lay out the conflicts of interest (relationship with industry, expert 
witness, expert speaker, and personal research) and had a policy that members could not 
vote or write on items. The voting items were recorded in the first and second 
appendices.    
Item: 22 23 Total 
Appraiser #1 7 7 14 
 
Domain #6 Score: 100%  
Overall Guideline Assessment 
1. Rate the overall quality of the guidelines  
a. I would rate the overall quality of this guideline poor to fair in the context of the 







answer the question. This is an important guideline for the procedure though, and 
recommendations for early ambulation and decreased TIB should be added for an 
overall picture of the PCI process in future guideline recommendations for PCIs. 
For this to happen, all healthcare providers and their tasks need to be taken into 
consideration.  
2. I would recommend these guidelines for use (yes, yes w/modifications, or no):  
a. Yes, but with major modifications. The information is invaluable to the practice 
and safety of a PCI, but would need further input for specific guidance of nursing 
cares from both medical and nursing studies. Currently it only infers data from 
populations, adjunctive therapies, and vascular compression devices and does not 
make any claims on the proper time in bed and the safe amount of time prior to 
ambulating.  
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BROUWERS ET AL.’S (2010) AGREE II TOOL FOR ROLLEY ET 
AL. (2011) 
PICO Question: 
(P) In adult patients undergoing PCI with a femoral access, (I) does early ambulation at or less 
than four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O) 
have any impact on a patient’s risk of vascular complications?   
Grading Criteria: 
High quality guidelines are 80% or greater in relation to the PICO question. Scoring 1 (strongly 
disagree) to 7 (strongly agree).  
Domain 1: Scope & Purpose 
1. The overall objective(s) of the guideline is (are) specifically described. (7)  
a. The overall objectives are easily found and specific. These are nursing specific 
clinical guidelines for the care of the percutaneous cardiac intervention (PCI) 
patient. Specific guidelines that address the PICO question are addressed and 
answered.   
2. The health question(s) covered by the guideline is (are) specifically described. (6) 
a. The health questions covered by the guidelines are not as easily found as the 
objectives, however when found, if someone wanted to write a guideline 
regarding this population on how to manage care before, during, and after a 









3. The population (patients, public, etc.) to whom the guideline is meant to apply is 
specifically described. (6)  
a. The population is patients undergoing a PCI, special populations that may impact 
outcomes include older age, women, anticoagulation therapy, repeat PCI 
procedure, and arterial access site management. These populations are listed in 
the introduction, but there is no special section on it and one has to dig through 
the guidelines to find more specifics. The proper care of the special populations 
would result, but it would benefit with special sections devoted to them, instead of 
organizing in the procedural phase. 
Item: 1 2 3 Total 
Appraiser #1 7 6 6 19 
 
Domain #1 Score: 94% 
Doman 2:Stakeholder Involvement 
4. The guideline development group includes individuals from all relevant professional groups. 
(6) 
a. These are nursing guidelines specific to PCI care with experts within the cardiac 
nursing field. All authors are professors of nursing at colleges in Australia, New 
Zealand, and the U.S. The question was given a score of (6), because important 
issues of a nursing cares during a PCI is not only a nursing process and would 
have benefited from other professional input (physician, advanced care providers, 







The term “expert interdisciplinary panel” (Rolley et al., 2011 p. 20) are used but 
the term is not defined on who look at the final guidelines prior to submission for 
publication.  
5. The views and preferences of the target population (patients, public, etc.) have been sought. 
(5) 
a. The views of the cardiac nurses have been sought in an online survey and a 
modified online Delphi Technique, and final input from “expert interdisciplinary 
panel” (Rolley et al., 2011, p. 20) had been sought, but there is no discussion 
regarding input from patients undergoing PCIs and their families.  
6. The target users of the guideline are clearly defined. (7)  
a. The target users of the population are nurses taking care of patients undergoing 
PCIs. This is clearly stated in the title and throughout the document.  
Item: 4 5 6 Total 
Appraiser #1 6 5 7 18 
 
Domain #2 Score: 83% 
 
Domain 3: Rigor of Development 
7. Systematic methods were used to search for evidence. (6) 
a. The literature review was in a systemic review article titled “Review of nursing 
care for patients undergoing percutaneous coronary intervention: a patient journey 
approach” by the same authors with the intent of publishing these results as 







listed, there was not clear audit trail of why articles were selected and some were 
not. The authors broadly looked for guidelines related to acute coronary 
syndrome, PCI, and secondary prevention, articles related to nursing cares of 
patients undergoing a PCI, systematic review of studies, and patient care 
guidelines using empirical methods. Reference lists of other articles and search 
engines such as Google scholar were also used.  
8. The criteria for selecting the evidence are clearly described. (6)  
a. As listed from the article, “review of nursing care for patients undergoing 
percutaneous coronary intervention: a patient journey approach” by Rolley et al. 
(2009), three broad guidelines for a search strategy were given based on 
interventional/descriptive studies describing nursing PCI cares, systematic 
reviews of these studies, and patient care guidelines.  
9. The strengths and limitations of the body of evidence are clearly described. (6) 
a. The GRADE system for evidence and recommendations was used and described 
within the guideline and system was used throughout all guideline 
recommendations. Limitations of evidence are harder to find within the document. 
In addition, there is ambiguous discussion regarding limitations within the 
guidelines or the literature review article. 
10. The methods for formulating the recommendations are clearly described. (7) 
a. The GRADE system for evidence and recommendations was used and described 









11. The health benefits, side effects, and risks have been considered in formulating the 
recommendations. (6) 
a. Harm is not discussed outright, but is implied through the guidelines graded and 
the amount of evidence behind the GRADE scale.  
12. There is an explicit link between the recommendations and the supporting evidence. (7) 
a. All recommendations are supported by literature and graded by the quality of their 
evidence by the type of study the evidence comes from. 
13. The guideline has been externally reviewed by experts prior to its publication. (5)  
a. The guidelines were reviewed by an outside inter-disciplinary group, but unsure if 
there were any methodological experts within the group.  
14. A procedure for updating the guideline is provided. (4) 
a. It is acknowledged in the conclusion that this is the “first step” (Rolley et al., 
2011, p. 34), in establishing guidelines for cardiovascular nursing care of a PCI, 
but there is not a procedure for updating, but acknowledgement that further 
research is needed.  
Item: 7 8 9 10 11 12 13 14 Total 
Appraiser 
#1 
6 6 6 7 6 7 5 4 47 
 










Domain 4: Clarity of Presentation 
15. The recommendations are specific and unambiguous. (7) 
a. The recommendations are specific to the population for which they apply.  
16. The different options for management of the condition or health issue are clearly 
presented.(6) 
a. The different options for management of different condition or health issues are 
present, but sometimes not well-organized.  
17. Key recommendations are easily identifiable. (6) 
a. Key recommendations are organized by part of the procedure, a lack of 
knowledge would make it hard to find. Recommendations are grouped in boxes 
within each section for ease of use.  
Item: 15 16 17 Total 
Appraiser #1 7 6 6 19 
 
Domain #4 Score: 84% 
Domain 5: Applicability 
18. The guideline describes facilitators and barriers to its application. (7) 
a. These are very specific guidelines for care and do acknowledge special 
populations throughout the chapters and specially addresses early ambulation 
caveats such as use of glycoprotein IIb/IIIa inhibitors and bivalirudin are 
addressed. 








a. These guidelines address specific practice questions of nurses and could easily be 
put into practice.  
20. The potential resource implications of applying the recommendations have been considered. 
a. Despite nursing time being considered a resource, the document does not address the 
amount of time or cost of nurses ability to monitor for all these complications, cost 
of medications, or cost of early ambulation, discharge, or complications cost.  
21. The guideline presents monitoring and/or auditing criteria. (6) 
a. The authors look to create nursing outcomes for the PCI process, but one has to assess 
the whole document to find them and they are overall quite vague. In regards to vascular 
complications, bleeding, hematoma, swelling, ecchymosis, and pseudo-aneurysms are all 
addressed.  
Item: 18 19 20 21 Total 
Appraiser #1 7 7 3 6 23 
 
Domain #5 Score: 79%  
Domain 6. Editorial Independence 
22. The views of the funding body have not influenced the content of the guideline. (7) 
a. Conflict of interest was addressed after the conclusion. No conflicts of interest 
were noted by any reviewers, participants, or researchers. It was acknowledged 
that the research was supported by a grant and part of a PhD program of research. 
It was also noted a research group called The Centre for Cardiovascular and 
Chronic Care Research from the Curtin Health Innovation Research Institute of 







administrative and technological support, but no financial support from either 
entity was reported.  
23. Competing interests of guideline development group members have been recorded and 
addressed. (6)  
a. Conflict of interest was denied and the organizations in # 22 involvement was noted, 
but there was no list of who was related to the PhD program or the credentials of the 
reviewers.  
Item: 22 23 Total 
Appraiser #1 6 6 12 
 
Domain #6 Score: 83% 
Overall Guideline Assessment 
1. Rate the overall quality of the guidelines.   
a. The overall quality of the guidelines is good. The guidelines address a gap in the 
literature and provide excellent guidance to nursing cares of patients who are 
undergoing a PCI that other guidelines lack. The guidelines would benefit from an 
interdisciplinary approach. 
       2.  I would recommend these guidelines for use (yes, yes w/modifications, or no): 
a. Yes, with minor modifications. I would use these guidelines to help establish policy 
and care of patients with PCIs, especially for post-procedural cares that address early 
ambulation. I would supplement with other research in order to get a full picture 
(input from the medical literature), but these guidelines are a good foundation to 
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